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Abstract
The regenerative potential of adult stem cell populations within the human body bears great
promises for their use in regenerative medicine. The bone marrow (BM) harbours two different
types of adult stem cells, haematopoietic stem and progneitor cells (HSPCs) and multipotent
mesenchymal stromal cells (MSCs), which are tightly regulated in their distinct anatomically
defined niches by multiple cues such as cytokines, cell-cell contacts, the extracellular matrix
(ECM) and the physical microenvironment. The ex vivo expansion of these cells for applica-
tions in regenerative therapies is of great interest and several biomaterial approaches attempt
to mimic the natural BM niche and its components to control stem cell maintenance and
differentiation. However, as of now the complexity of such stem cell niches is hard to recapit-
ulate. Towards this goal, this work was focussing on the ECM environment of BM stem cells
and was set out to engineer improved in vitro culture systems. MSC themselves are one of
the most important cell types within the BM that secrete and construct ECM-networks and
thereby shape the microenvironment of the residing cells. The potential of primary human
BM-MSC to secrete ECM in vitro has been exploited to generate niche-like ECM surrogates in
a robust and versatile format. Application of decellularisation regimes allowed the fabrication
of complex matrices which demonstrated suprastructural, compositional and physicochemical
properties compareable to those of the native BM-ECM environment. Reliable stability and
reproduciblity was achieved by a dedicated procedure of maleic anhydride co-polymer-mediated
covalent binding of fibronectin and subsequent anchorage of cell-secreted ECM molecules. As a
result of the high reproducibility, a complete proteomic register of ECM molecules was obtained
in combination with determining the complex fibrillar and soft gel-like characteristics of MSC-
derived matrices. Based on the established BM niche-like substrate, the impact of extracellular
matrices on MSC and HSPC ex vivo behavior has been explored. Both cell types demonstrated
strong adhesion to ECM substrates and depicted a changed cellular morphology upon contact
with native ECM structures compared to standard culture substrates or simple ECM protein
coatings, indicating an intense interplay between the cell and the microenvironment. MSC that
re-grew into their own matrices have shown advantageous proliferation and cytokine secretion
levels as well as enhanced differentiation intensity (upon differentiation induction) compared to
MSC that were cultured on less complex substrates. Similarly, HSPC were also instructed for
enhanced expansion on MSC-derived matrices without exhaustion of stem cell-marker express-
ing progenitor cells. The efficiency of these matrices was related to their ability to mimic the
native composite suprastructure, ligand nano-topography, molecular composition and phys-
ical properties of natural BM ECM environments. The data obtained within this thesis set
the ground for a more rational design of artificial stem cell niches with defined and distinct
properties, offering exciting options for the in-depth analysis and understanding of stem cell
regulation by exogenous cues.
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2D Two-dimensional
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Chapter 1
Introduction
1.1 Motivation
Increasing demand for the treatment of tissue loss and organ failure following traumatic, de-
generative or malignant destruction is a major concern of todays health care systems. The
traditional treatment for tissue reconstruction is autologous or allogeneic harvest of a variety
of tissues or organs from a healthy donor site and transplantation into the diseased patient
(e.g. kidney or bone marrow transplants) [1]. Implantation of mechanical devices such as
heart valves, stents or prostheses are a practicable alternative [2]. However, the lack of organ-
donor availabilty and complications such as graft-rejection, donor site morbidity, and the risk
of implant infection or thromboembolism are major limitations. Regenerative medicine offers
a different direction of new therapeutic strategies, which have the potential to overcome these
limitations of classical reconstruction and transplantation therapies.
Regenerative medicine is an interdisciplinary field of stem cell biology, bioengineering, tissue
engineering and cellular therapies which aims at the development of biological substitutes that
are able to restore, maintain or improve tissue and organ function [3]. Combined principles
of life sciences and engineering are applied to develop in vivo and ex vivo cellular treatments
involving genetic manipulation, molecular and pharmaceutical treatment, and seeding cells
onto functionalised and 3-dimensional scaffolding materials. The possibilities within the field
of regenerative medicine lead to high aspirations for current biomedical research. Resarch
strategies include endogenous regeneration of degenerated tissues by means of gene therapy or
cell tranplantation, but also more complex strategies such as complete replacement and recon-
struction of disfunctional or damaged tissues by application of fabricated tissue engineering
constructs [3]. However, the required specialised and functional cell types can mostly not be
harvested from the diseased organ or are not available in sufficient numbers to mediate re-
generative efforts. New approaches make use of the bodies endogenous system of regeneration
and repair via stem and progenitor cells. These cells can be found in almost every type of
tissue and they are a valuable cell source with the capacity for self-renewal and differentiation
into various specialised lineages [4]. Within the last decade, research has put a lot of effort
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into the establishment of regenerative therapies that use the potential of embryonic and adult
stem cells to generate replacement tissues or to improve tissue function. Despite their wide-
spread potential and steady progress towards clinical use, a major drawback is the difficulty
to increase tissue-specific stem cell numbers without loss of stem cell potential and to control
stem cell fate towards a specialised and functional cell type of interest. This is in contrast
with the in vivo potential of those cells, where they exhibit extensive self-renewal capacity and
facilitate the offspring of numerous mature cells throughout the lifetime of an individual. The
general concept behind this phenomenon is the idea that adult stem cells reside in specialised
microenvironments - so called niches - that coordinate self-renewal (the process of cell division
that creates two identical stem cell type daughter cells without differentiation) and initiation of
differentiation (the process of altering the cells genotype causing specialisation towards a ma-
ture cell type). Microenvironments regulate growth, self-renewal and cell-fate by an interplay
of four signalling sources, namely (i) soluble growth factors, (ii) cell-cell interactions, (iii) insol-
uble extracellular matrices and (iv) environmental stress and physical cues [5]. Importantly the
combined interplay between all these signalling sources is pivotal to the efficient and correct
stimulation of cellular response and regulates proliferation, migration, survival, self-renewal
and differentiation. A fundamental unit that controls this interplay is the extracellular matrix
(ECM), which builds up a 3-dimenstional scaffold for directed cell-cell interaction and spatial
presentation of soluble growth factors and adhesion ligands, as represented in figure 1.1.1.
Figure 1.1.1: The extracellular matrix provides an instructive microenvironment
Fibrous structures of the ECM provide topographical features and trigger morphogenesis. Incorporated adhesion
molecules (for example fibronectin and laminin) contain recognition sequences to interact with transmembrane
integrin receptors of the cell to activate intracellular signalling pathways, which regulate cellular behaviour.
Glycosaminoglycans (such as hyaluronic acid and heparan sulfphate) serve as a depot for soluble growth factors
and cytokines and aid their functional presentation. Graphic adapted from [6].
Todays most successful clinical application of stem cell therapies is the use of bone marrow stem
cells for the treatment of haematological disorders, malignancies and bone defects [7, 8]. The
human bone marrow harbours two types of adult stem cells, namely multipotent mesenchymal
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stromal cells (MSC) and haematopoietic stem cells (HSC). Both cell types offer an enormous
regenerative potential and are tightly regulated in their distinct anatomically defined niches
[9]. Bone marrow niches are the most intensely studied stem cell microenvironments [10, 11].
To pursue the advanced use of bone marrow stem cells in regenerative medicine, the availability
of ex vivo expanded or pre-differentiated cells would be enormously beneficial, but implies a
detailed control of stem cell behaviour. Intrinsic to the therapeutic stem cell concept is the field
of stem cell bioengineering. This “endeavor focusses on quantitative description of stem cell
fate processes and the use of this information for the development of clinically and industrially
relevant cell-based technologies” [12]. Therefore, the study of microenvironmental conditions
for the control of stem cell behaviour is one critical step towards controlled manipulation of
cells outside and inside the human body. As it was mentioned above, the extracellular matrix
is the native surrounding of cells and serves as a guiding structure for cellular regulation and
tissue development. The mimicry of extracellular matrix properties of the microenvironment
is the gold standard for biomaterials approaches in regenerative stem cell biology [13].
Biologic and artificial materials have been used to create tissue engineering substrates that
mimic ECM components and control stem cell fate [14, 15, 16]. These approaches include (i)
the use of synthetic components without the addition of bioactive components, (ii) biopolymer
based strategies using native ECM components (iii) biohybrid systems with combined syn-
thetic and biomolecular components and (iv) biohybrid systems that use synthetic materials
in combination with bioactive sequenes. Conventional synthetic materials like nylon meshes,
silicone scaffolds, or poly(ethylenglycol) gels have the advantage to create highly reproducible
scaffolds with control over the materials properties, but they allow only little control over
cell behaviour and lack biological activity. Biopolymer based approaches facilitate isolated or
recombinant components of the extracellular matrix and have been used to create extracel-
lular microenvironments by immobilisation of single or combinatorial ECM molecules or for
example by reconstitution of natural collagen assemblies. Materials with dual character com-
bine synthetic substances with incorporated biomolecular functionalities to mimic structural
and functional aspects of the natural ECM in conjunction with stimulation of cellular recept-
ors. For example, cellular recognition sequences or receptor binding domains, growth factors
and signalling ligands, enzyme sensitive peptides and glycosaminoglycans are incorporated into
synthetic polymers such as poly(ethylen glycol) [17]. Such materials that are designed to mimic
the stem cell niche and control stem cell behaviour have been able to directly link extracellular
cues to a cellular response [18].
Although alot of engineering effort is put towards mimicking the natural environment these
materials can not compete yet with the ability of biologically derived materials in terms of a
wholistic cellular stimulation and structural guidance. The natural ECM environment com-
prises a complex anisotropic topography with integrated adhesion and recognition sites for
directed cellular regulation. Furthermore they are susceptible to cellular proteolytic degrad-
ation and remodelling of the growing tissue. Most realistic similarities in ECM composition,
microstructure and biomechanical properties have been conducted with decellularised extra-
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cellular matrix products. These have the ability to most naturally reconstitute a functional
tissue environment. Advantageous is the possible use of allogeneic or even xenogenic decel-
lularised donor material, which can be seeded with autologous cells and omits the need for
immuno-suppression post transplantation [19]. Next to the use of decellularised organs also
decellularised in vitro cultures have become more and more interesting for the study of cellular
behaviour in a native 3-dimensional environment. Cell-generated decellularised matrices have
been used to analyse the regulation of stem cell functions. For example, embryonic stem cells
that are routinely cultured together with a layer of feeder cells have been cultured on matrices
derived from embryonic fibroblasts. Human embryonic stem cells could be maintained in a
self-renewing and pluripotent state when they were cultured on these matrices [20]. This
demonstrates the power of decellularised matrix substrates for the culture and expansion of
stem cells ex vivo and for the detailed analysis of stemness maintaining conditions. Import-
antly, the composition and character of the extracellular microenvironment is characteristic for
each tissue specific ECM and demands the generation of tissue-specific extracellular matrices
to mimic particular stem cell niches [19].
For a better understanding of the regulatory interplay between the extracellular matrix of
the bone marrow niche and the residing stem cells a culture system needs to be established
and characterised that closely resembles the native microenvironment. As it was mentioned
above, decellularised matrices of tissues, organs and cultured cells have the highest poten-
tial to resemble native ECM environments. The concept of decellularisation has been used
successfully for the creation of tissue engineering scaffolds for medical applications, but also
for the creation of cell-type specific cell culture substrates that resemble tissue-specific ECM
compositions. MSC and their differentiated progeny of the bone marrow have been used to
create decellularised ECM coatings for implant materials, or to enhance differentiation into the
osteogenic lineage [21, 22]. However, the use of MSC-generated ECM for the creation of a stem
cell niche that can promote self-renewal and expansion of primitive progenitors for both bone
marrow stem cell types - MSC and HSPC - still remains an open challenge. Furthermore, the
creation of stable, reproducible matrices made by bone marrow MSC, which can be analysed
for all their constituents and physicochemical characteristics would serve a great advancement
for the study of stem cell behaviour within their niches.
1.2 Objective
The niche of multipotent mesenchymal and haematopoietic stem and progenitor cells (MSC and
HSPC) is regulated by close interaction with the extracellular matrix. To generate extracellular
matrices that resemble the bone marrow environment the idea was to use MSC themselves,
since they are known to be major regulators of the niche and produce large amounts of ECM
within the marrow cavities [23, 24]. The aim of this study was to generate naturally derived
ECM scaffolds and utilise them as a versatile stem cell culture substrate. The matrices should
be prepared in a way that their complex molecular composition could be analysed in detail and
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therefore allow to dissect the different cues influencing a certain response of scaffold-cultivated
stem cells. In fact, in 1995 Klein et al. have tried to analyse the intricate composition of
the bone marrow environment and managed to reveal some of the extracellular players of the
niche [23]. Since then many other studies have followed this approach, but a comprehensive
description of bone marrow extracellular niche characteristics and their functional mechanisms
is still elusive. Kleins statement of 1995 is still valid today: “Since it is becoming more and more
evident that the extracellular matrix is far more complex, a refined analysis of the extracellular
matrix production by these stromal cell lines will be necessary”. Thus, this study is aiming at
using human primary MSC to generate decellularised matrices in the most possible in vivo-like
manner and to make them applicable as well-defined and adaptable scaffolds for ex vivo culture
of bone marrow derived stem cells.
The strategy to reconstruct the interplay of bone marrow MSC and HSPC with their natural
extracellular microenvironment in vitro is shown in figure 1.2.1. It illustrates the action of
the extracellular matrix as key instructor of cellular phenotype and behaviour. The whole
complexity of ECM intrinsic characteristics, such as suprastructural topography and physico-
chemical properties can be presented best by natural structures such as decellularised matrices
to reveal their full potential for bone marrow stem cell engineering. Specifically, decelluarised
culture substrates can provide physiological and complex extracellular environments to study
authentic cell-matrix interactions and regulation of cellular behaviour. Thus, in an effort to
create potent culture systems based on decellularised cell-made scaffolds for the expansion and
differentiation of bone marrow stem cells, the following main goals had to be addressed within
this thesis:
(A) Establishment of a robust and reproducible decellularised matrix substrate that mimics
the tissue-specific extracellular environment of the bone marrow; generated by primary
bone marrow MSC in vitro.
(B) Identification of the molecular constituents of decellularised matrices and analysis of their
topographical and physical properties, to elucidate the mechanisms of action of the ma-
terial.
(C) Probe the potential of bone marrow specific decellularised matrices for support and ex-
pansion of tissue specific MSC and HSPC outside the human body, accompanied by the
analysis of cellular behaviour.
Finally, this study could help to open new perspectives towards efficient cellular treatments
within stem cell-based regenerative medicine approaches.
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Figure 1.2.1: Reconstruction of bone marrow stem cell microenvironments ex vivo
The natural in vivo situation of the human bone marrow stem cell niche serves as a guiding and starting
point from where to engineer in vitro stem cell microenvironments for the control of stem cell self-renewal and
differentiation.
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Fundamentals
This chapter gives and overview of the fundamental background information needed to under-
stand the scope of this thesis. First, the structure, composition and functions of the extracel-
lular matrix are introduced. Next, bone marrow and residing stem cells are presented together
with their regulation by the in vivo niche. Following, current concepts of bone marrow stem cell
bioengineering will be introduced, focussing on biomaterials to direct stem cell fate. Finally,
strategies for decellularisation of extracellular matrices and their use in regenerative medicine
and stem cell biology are presented.
2.1 The extracellular matrix as biological scaffold
For the successful development of artificial stem cell niches it is crucial to recapitulate the
natural environmental conditions that control stem cell fate. In vivo, cells derive a continuous
flow of information from their surrounding extracellular environment. The extracellular matrix
(ECM) encloses and separates cells within their tissue and instructs the fulfillment of specific
genetic programmes which determine cell and tissue behaviour. Artificial scaffolds that aim
at reconstruction of stem cell niches must be able to take on this instructive role in order to
control cell behaviour as if they were in their native environment. The natural ECM scaffold is
the master-guideline for the design and engineering of scaffolds for regenerative medicine [25].
The following section will introduce components and functions of native ECM and describe its
role as natural biological scaffold.
2.1.1 Structure and composition
The ECM is an intricate three-dimensional network composed of a variety of structural and
functional molecules that include the collagen family, elastic fibres, proteoglycans and glycosa-
minoglycans (GAG), and adhesive glycoproteins [26] (Figure 2.1.1). The ECM is the secreted
product of tissue resident cells and different combinations, immobilisation, and spatial organ-
isation of these secreted molecules gives rise to unique and characteristic tissue-specific scaffolds
7
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[27]. The ECM serves as structural support, provides mechanical strength and guides cell-cell
and cell-ECM signalling events. Intrinsic to its structure and composition, the ECM provides
adhesion sites for cell surface receptors and serves as a reservoir for morphogens and growth
factors. Thereby, the ECM acts as a key regulator of a variety of cellular processes, such as
proliferation, survival, differentiation, migration and overall tissue homeostasis [26]. The com-
ponents of the ECM can be categorised into two main classes of molecules. One, fibrous and
adhesion proteins, which mediate mechanical stability and facilitate spatially defined and chem-
ically specific adhesion sites. And two, proteoglycans and glycoproteins, which are commonly
composed of a core protein that is posttranslationally modified with mucopolysaccharide chains
(GAG), offering hydration and pressure resistance to the ECM. Furthermore, proteoglycans also
support cell adhesion and function as a depot for growth factors within the ECM [26].
Figure 2.1.1: The extracellular matrix
The extracellular matrix consists of structural proteins, adhesion proteins and proteoglycans. Graphic adapted
from [28].
It is to note that many ECM molecules have overlapping functions, which does not allow a
strict division into structural and functional groups. The interplay between ECM molecules
imparts further diversity and functionality to the extracellular environment and changes in
response to environmental cues. The bidirectional flow between cells and their ECM triggers
constant reorganisation, degradation and synthetisation of ECM structures. All these molecular
interactions prime cellular responses towards differentiation, proliferation, migration, wound
healing or apoptosis [27, 29].
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Fibrous proteins
Fibrous proteins within the ECM are collagens, elastin, fibrillin and fibulin. The most prom-
inent fibrous protein is collagen. Collagen is also the most abundant protein in the vertebrate
body, comprising more than 90% weight of the ECM from most tissues and organs [30]. This
heterogeneous class of proteins contains up to 20 different collagens which exhibit different
biological functionalities [27]. Collagens contain three polypeptide α-chains, displaying a triple
helical conformation which is the characteristic feature of the collagen superfamiliy. Each
polypeptide chain has a repeating Gly-XY triplet in which glycyl residues occupy every third
position and the X and Y positions are frequently occupied by proline and 4-hydroxyproline,
respectively [30]. The collagen family is categorised into subfamilies, that are fibrillar colla-
gens (type I, II, III, V, XI), fibril-associated collagens with interrupted triple helices (FACIT)
(type IX, XII, XIV), transmembrane (type XIII, XXV), network forming (collagen VIII, X)
or basement membrane collagens (collagen type IV), according to their supramolecular as-
sembly. In addition to their mechanical and structural functions, collagens play important
roles in determining cell attachment and spreading as well as influential roles in cell migration
and differentiation [27]. Along with collagen, elastin is another major structural ECM pro-
tein. Individual tropoelastin subunits are crosslinked together to form the mature elastin fibre.
Elastin co-fibrils together with fibrillin inherit reversible extensibility and are responsible for
the flexibility of many tissues [31].
Adhesive glycoproteins
Adhesive glycoproteins are a class of ECM molecules that occur in several variant forms and
offer multiple binding domains which are capable of binding collagens, proteoglycans and cell
surface receptors. Members of this class of ECM molecules are fibronectin (FN), laminin,
vitronectin, thrombospondin, tenascin and others [32]. Fibronectin is the most studied adhesive
glycoprotein. It is secreted as a disulfide-bonded dimer and is assembled into insoluble fibrils
via a cell-mediated process. Variant forms of FN exist, which arise from alternative splicing
of the mRNA precursor. Both dimers are nearly identical and contain FN type I, type II
and type III repeats which possess specific recognition sequences for cellular interaction and
interaction with other ECM proteins [33]. Sequences that are responsible for cell binding are
RGD (Arg-Gly-Asp), RGDS (Arg-Gly-Asp-Ser), LDV (Leu-Asp-Val), and REDV (Arg-Glu-
Asp-Val) [26], wherby the RGD sequence is a very frequent recognition sequence also present
in many other ECM proteins. Due to its binding sites that can activate cell surface integrin-
receptors, FN is a key player for cell attachment, cell movement, differentiation and multiple
developmental processes [34]. FN is not only a mediator of diverse cell-matrix interactions,
it also contains binding sites for other ECM molecules such as collagen, fibrin and heparan
sulfate proteoglycans, thereby playing a major role in organising the components of the ECM
[29].
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Glycosaminoglycans and Proteoglycans
GAGs are long unbranched polysaccharides existing of repeating disaccharide units, which are
either a hexose or hexuronic acid, linked to a hexosamine. Depending on the type of hexosa-
mine, hexose or hexuronic acid (e.g. glucuronic acid, iduronic acid, galactose, galactosamine,
glucosamine) and the geometry of the glycosidic linkage different types of GAGs include the
galactosaminoglycans, chondroitin sulfate and dermatan sulfate and the glycosaminoglycans
heparan sulfate, heparin, and keratan sulfate [35]. All GAGs can be associated to a core
protein backbone and thereby appear as so-called proteoglycans. Hyaluronan is an exception
to this and is also the only GAG that does not occur in a sulfated state. The net negative
charge of proteoglycans attracts water molecules and mediates their ECM hydration function-
ality. Examples of proteoglycans and their core proteins are glypicans, syndecans, perlecan,
versican, aggrecan and decorin. Proteoglycans and GAGs can occur associated to the cell
surface or interact between each other and other ECM components, such as laminin, colla-
gen and fibronectin. Another key structural role of proteoglycans is their contribution to the
ECM architecture and permeability and their functional importance in combination with other
ECM molecules to influence coupling, release and presentation of specific growth factors and
morphogens [36].
ECM proteases
Cell movement and tissue remodelling are important processes which require ECM degrad-
ation [37]. These mechanisms are accomplished by ECM proteases, which can be devided
in the family of matrix metalloproteinases (MMP), the family of A disintegrin and metallo-
proteinase wtih thrombospondin motif (ADAMTS) and the heparan sulfate-degrading enzyme
heparanase [29]. In mammals 24 MMP proteins have been identified as either membrane bound,
transmembrane-proteins or secreted proteins. The majority of ECM degradation is carried out
by cell-associated MMPs [38]. To maintain tissue homeostasis, their activity is highly regulated
at the level of transcription, by requirements for proteolytic processing before they become act-
ive, or by tissue inhibitors of metalloproteinases (TIMPs). ADAMTS are similarly regulated
and together with MMP paly important roles for processing membrane bound precursor pro-
teins such as Notch, Delta and other growth factors to release active molecules [39]. Apart
from protein degradation also heparan sulfate ECM components can be degraded. Heparanase
is an endoglucuronidase that is crucial to the removal of heparan sulfate crosslinkers of ECM
proteins, to release heparan sulfate-bound growth factors, and to release oligosaccharides from
heparan sulfate to regulate protein-protein binding [29].
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2.1.2 Function and regulatory cues
The described biochemical, structural and mechanical properties of the ECM are essential to
the regulation of cellular functions such as cell adhesion, proliferation, migration, differentiation
and cell death by their respective tissue-specific ECM surroundings [40]. ECM biochemical cues
mostly comprise biomolecules, which are involved in binding and activation of cell membrane
receptors to control downstream signalling events and ultimately cellular phenotype, and me-
diate the storage functionality for soluble signalling molecules. Mechanical, structural and
physical characteristics of the ECM govern tensile strenght, cushioning and filter functions as
well as geometric and topographical guidance for cellular growth and tissue formation [40]. In
fact, it is very difficult to distinguish the biomolecular and physical cues since they often occur
in combination with each other, represented by complex interwoven ECM assemblies. This
section will discuss separate and combinatoral instructive effects of the ECM.
Biochemical signals
Most of the ECM molecules contain multiple adhesion and recognition sites for specific cell-
ECM crosstalk [41]. Extracellular signals are transmitted into the cell via cell surface receptors
which recognise specific ECM adhesion domains and display differential binding affinities to-
wards their ligands. The most important group of cell surface receptors are integrins, which
mediate the crosstalk between biochemical and mechanical cues of the ECM to the interior cyto-
skeleton of the cell. Integrins are heterodimeric trans-membrane receptor glycoproteins which
consist of eighteen α subunits and eight β subunits, which are non-covalently assembled into
24 different combinations [42, 43]. The interplay between the cell and the ECM is dependent
on the specific integrin expression pattern on the cell surface and dictates which ECM signals
can be sensed from the environment. Mechanisms of integrin mediated signal transduction
are presented and described in figure 2.1.2. Furthermore, non-integrin cell surface receptors
exsist, which are transmembrane proteoglycans like syndecan, CD44 and laminin receptors.
In response to the recieved signals of the ECM the cell can alter its phenotype or return the
recieved information in an inside-out signal transduction fashion via changes in cell surface
receptor expression or secretion of ECM proteases which results in active remodelling of the
ECM environment [37]. Another mechanism based on the molecular composition of ECM is
the interaction between growth factors and growth factor-binding proteins with extracellular
molecules, which regulates cell behaviour on various levels. Proteoglycans and their GAG
side chains play a crucial role in mediating the binding and mobilisation of growth factors,
cytokines and morphogens for their functional presentation to the cell. Biological activity,
spacial distribution, local concentrations and concentration gradients of growth factors are
controlled by direct binding to the ECM [44, 45]. Reciprocally, transcription, translation and
post-translational modification of ECM macromolecules are regulated by various growth factors
[46]. The collaboration between growth factors and ECM molecules is an important aspect of
distinct cellular environments or niches and regulates cellular genotype and phenotype.
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Figure 2.1.2: ECM and integrin signalling
Simplified schematic of signal-transduction events via transmembrane integrin receptors. (A) A specific reper-
toire of αβ-integrins is expressed on the cell surface of a particular cell type and can specify which signalling
pathways are activated upon differential binding affinity to ECM ligands and recognition sequences. ECM stiff-
ness and topography are further important regulators to initiate signalling pathways. Clustering of integrin/actin
complexes strengthens focal adhesions and initiates the assembly of adhesomes. (B) The cytoplasmic domains of
integrin receptors recruit adapter proteins to the plasma membrane which can regulate growth factor signalling
in conjunction with other growth factor receptors. (C) In response to growth factor stimulation, integrins co-
localise with growth factor receptors at focal adhesion sites associated with cytoskeletal molecules such as paxillin,
talin and vinculin, and signalling molecules like focal adhesion kinase. Eventually downstream effectors such as
AKT-Kinase, MAPKinase and Rho GTPases are activated which tramsmit signals usually via phosphorylation-
signalling cascades to the nucleus. Graphic adapted from [29].
Mechanical signals
Physicochemical cues of the ECM are mechanical and structural signals which act on the
residing cells within a tissue [47]. Tissue elasticty is the product of precise ECM composition
and structural processing of ECM molecules. Each tissue harbours its own specific tissue-
stiffness and thereby is representative for the mechanical environment of the embedded cells
and their mechanical instructions. Varying tissue elasticities are shown in figure 2.1.3. On
the cellular micrometre level, elasticity is conducted by the flexiblity and extensibility of ECM
molecules such as collagens or elastins. Most of the mechanical interactions between the cell
and the ECM are integrin-mediated cell adhesion and mechanotransduction processes, which
link the mechanical properties of the ECM to the cellular cytoskeleton, where cytoskeletal
stresses are propagated into cellular motility which can evoke additional mechanical signals.
In response, cells can take on differential morphologies and rearrange the ECM by means of
tensile forces [48, 49]. Cycles of mechanosensing of a local force geometry, mechanotransduction
via integrin receptors and mechanoresponse by intracellular transduction of tensegrity into
biochemical signals result in responses that regulate cell growth, differentiation, shape changes
and cell death and ultimately tissue homeostasis [50].
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Figure 2.1.3: Elasticity of tissues
ECM micoenvironments are physically diverse and tissue elasticity is the product of tissue-specific ECM
composition and ECM processing. Cellular response to the environment is not only dependent on
biochemical cues but also on the combinatorial physico-chemical effect of the ECM which regulates
tissue-specific cell fate and behaviour. Graphic adapted from [51].
Structural signals
The presented biochemical and mechanical cues of the ECM are mediated by cell surface re-
ceptors that recognise specific structural features of ECM molecules. It is very important to
note that only a few specialised tasks of the ECM are reserved for isolated molecules, but in
principal, proper ECM functionality relies on the presence of suprastructural elements which
originate from ECM polymerisation into insoluble fibrils, micro-fibrils and networks that are as-
sembled into regional structures (i.e. fibres or basement membranes) [52]. This suprastructural
conformation determines the ligand topography by which nano-scale and macro-scale patterns
of biochemical and physical cues are presented to the cell. Importantly, ECM stucture and
topography also actuates as contact guidance for the development, orientation, alignment and
migration of cells within their 3-dimensional environment. In combination with biochemical
and mechanical signals, like ECM-protease-mediated or stretch-mediated exposure of cryptic
binding sites within ECM structures, more complextiy is added to the versatile mechanisms
of action how ECM environments regulate cellular behaviour and tissue formation [53]. The
principles by which suprastructural elements control cell-functional consequences are not fully
identified. Further research is necessary to understand the impact of the complex ECM supra-
structural organisation on the assembly of natural cellular environments.
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2.2 Bone marrow residing stem cells
Stem cells are defined as “clonogenic cells capable of both self-renewal and multilineage differ-
entiation“ [54]. The earliest and most primitive type of stem cells are embryonic stem cells,
which are described as totipotent cells capable of generating all cell types of the adult body.
In contrast, adult stem cells reside in most adult tissues and exhibit multipotent properties for
differentiation into a range of tissue-specific cell types. Throughout development and growth
they can undergo a phase of rapid proliferation and differentiation to form tissues and organs.
In the adult they exist in a quiescent or dormant state for longer periods until they become
activated by injury or disease to fulfill their regenerative functions. Repeated entering into
the cell cycle and return to quiescence are tightly controlled by distinct cues of the stem cell
microenvironment or the so called ’niche’. Extrinsic cues such as cell-cell contacts between
stem cells and niche supporting cells and their ligands, as well as stem cell interactions with
the ECM regulate self-renewal and differentiation behaviour [55].
The bone marrow (BM) is one organ of the adult body that contains two types of adult stem
cells with fundamental roles for homeostasis which is mediated via their enormous regenerative
potential [56, 57]. These adult stem cells are haematopoietic stem cells (HSC) and mesenchymal
stem cells (MSC). HSC are responsible for the BMs main function as haematopoietic organ,
where developing HSC-derived progenitor cells are retained within the marrow until they have
matured and are released into the vascular system. MSC also reside within the bone cavity
and play important roles for skeletal development, for the formation of other mesodermal cell
lineages, for mediating anti-proliferative, anti-inflammatory and immunoregulatory effects, and
importantly for close interaction and support of HSC [24]. BM is distinguished into red marrow
and yellow marrow, both containing numerous blood vessels and capillaries [58]. Red marrow
is the place for active haematopoiesis and is found in flat bones and in the cancellous and
trabecular epiphysis of long bones. This is also the place where HSC predominantly reside.
Yellow bone marrow consists mainly of fat cells and is found in the medullary cavity of long
bone diaphysis. With age, the amount of yellow marrow increases, but in cases of severe blood
loss, yellow marrow can be reverted back into red marrow to increase blood formation. MSC
are found in both marrow types where they contribute to BM stroma, consisting of reticular
cells, perivascular cells, osteoblasts, osteoclats and adipocytes [11, 56]. This following section
will introduce the characteristics of both stem cell types and their interplay and regulation
within BM stem cell niches.
2.2.1 Mesenchymal and haematopoietic stem and progenitor cells
The definition of adult stem cells claims their multipotent character with the ability to differ-
entiate into specialised cell types. MSC and HSC have this ability and can generate mature
cell types with various properties, as shown in figure 2.2.1. HSC are the most primitive haema-
topoietic cells and are the precursor for all mature blood cells. HSC differentiate into myeloid
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or lymphoid progenitor cells, and controlled regulation of gene expression drives onward differ-
entiation into cells with more and more specialised functions. These two branches of progenitor
cells lead to the production of cells such as macrophages, neutrophils, erythrocytes, eosinophils,
monocytes, basophils, megakaryotcytes and platelets in the case of myeloid progenitor cells;
and T cells, B cells and natural killer cells in the case of lymphoid progenitor cells. Since my-
eloid progenitors are very short lived their supply from HSC is imperative [59]. MSC have the
ability to differentiate into a range of mesenchymal tissue cell types, including bone, cartilage,
stroma, tendon, adipose and evidence suggested even greater plasticity for differentiation into
non-mesenchymal tissues including muscle, liver, heart, skin and nervous tissues [60, 61].
Figure 2.2.1: Multipotency of HSC and MSC
Bone marrow hematopoietic stem cells (HSC) and mesenchymal stem cells (MSC) and their differentiation
lineages. Graphic adapted from abcam.com.
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Mesenchymal stem cells
The first time MSC were identified as multipotent stromal precursor cells was in 1970 by
Friedenstein et al.. He described the isolation of mononuclear cells (MNC) from bone mar-
row, which were adherent spindle-shaped clonogenic cells that he termed colony-forming unit
fibroblasts (CFU-F) [62]. Later in 1991, Caplan coined the term ’mesenchymal stem cell’ to
describe BM-derived stromal cells and their multipotency[63]. Various other synonyms can
be found in the literature including mesenchymal stromal cells (MSC), bone marrow stromal
cells (BMSC), marrow-isolated adult multipotent inducible cells (MIAMI), multipotent adult
progenitor cells (MAPC) and many more [64]. MSC can also be isolated from other tissues
like adipose tissue or cartilage 65, but BM is the predominant source for MSC research. The
commonly accepted proof for identification of MSC includes formation of CFU-F in culture,
multi-lineage potential (in particular osteogenic, chondrogenic and adipogenic) and expression
of a set of surface markers [61]. However, so far no consensus has been reached for the proof
of MSC self-renewal and for the definition of a specific set of phenotype markers to indentify
MSC from the heterogenous stromal cell population. Minimal critera for defining MSC have
been postulated by the International Society for Cellular Therapy [66]. MSC isolated from
bone marrow or other tissues must exhibit plastic adherence in standard culture conditions,
multipotent differentiation as mentioned above, and >95% of the population must show ex-
pression of CD73 (ecto-5´nucleotidase), CD90 (Thy-I) and CD105 (endoglin) and less than 2%
are allowed to express haematopoietic or endothelial markers CD45 (pan-leukocyte marker),
CD11b (monocyte) or CD14 (macrophage), CD19 or CD79α (B-cells) and HLA-DR (marker
for stimulated MSC) [66]. Other markers that have been identified on MSC include CD271
(low-affinity nerve growth factor receptor) [67] and CD146 (MCAM) [68]. CD146 identifies a
population of subendothelial cells with osteogenic, adipogenic and chondrogenic potential which
can support the haematopoietic environment. The functions of BM-MSC involve formation of
skeletal tissue within the marrow cavity, secretion of soluble factors involved in haematopoietic
development, pericyte functions in support of BM sinusoids and maintenance of the structural
environment by secretion and remodeling of ECM [69]. All these functions demonstrate the
crucial role of MSC for the formation of BM microenvironments that control tissue-specific
cells and importantly also HSC [70, 71] (see section 2.2.2).
Haematopoietic stem and progenitor cells
More than 40 years ago HSC have been recognised as blood forming cells [72]. The enormous
potential of these primitive stem cells has been shown by the fact that only one single HSC is
able to regenerate the entire haematopoietic system of an organism [73]. The majority of adult
HSC resides within the BM, but also at lower frequencies in extramedeullary tissues such as
the spleen [74]. Similar to MSC, the cell surface phenotype for HSC specifies different subsets
of stem cell populations, but has not been determined to such accuracy to be able to define
‘true’ stemness of HSC. Most of these definitions are available for murine HSC. For human
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HSC a surface marker profile of CD34 (transmembrane sialomucin), CD133 (prominin-1) and
CD90 and the absence of CD38 (cyclic ADP ribose hydrolase) and lineage markers describes a
fairly homogenous population of human HSC [75, 76, 77]. HSC can leave the BM and circulate
the peripheral blood upon injury and mobilisation, and in return they can home to the bone
marrow instructed by signal gradients from the niche. Stromal cell-derived factor 1 (SDF-1, also
called CXCL12) is expressed by stroma and endothelial cells and interaction with its receptor
CXCR4 (CXC-motive-chemokine receptor 4) expressed on HSC plays a key role in human
HSC trafficking to the BM microenvironment [78]. Signalling pathways that are involved in
HSC self-renewal within the niche are for example Notch signalling, Wnt/β-catenin signalling,
BMP and TGF-β signalling or prostaglandin signalling [79, 80]. Signal transduction via these
pathways results in molecular changes of transcription factor interaction with DNA sequences
of HSC-regulatory genes. Thus, the gene expression profile responsible for self-renewal can be
altered or maintained in response to the environment. Furthermore, HSC can be influenced
by a variety of cytokines, which regulate haematopoietic development at various stages [81].
The ones that have been found useful for the support of ex vivo expansion of self-renwing HSC
are, interleukin-3 (IL-3), IL-6, thrombopoietin (Tpo), stem-cell factor (SCF) and fms-related
tyrosine kinase 3 (Flt-3) [82, 83, 84].
2.2.2 Microenvironments and niches
The concept of the stem cell niche was first described by Schofield in 1978 [85]. His model
postulated that the conditions within the niche support stem cell activity and self-renewal
by maintaining quiescence or promoting differentiation in response to environmental cues.
Today this model has been extended, and the decission between self-renwal or differentiation
upon environmental stimulation is thought to be regulated via symmetric or asymmetric cell
division. Cell-divisional asymmetry (one daughter cell contains cell-fate determinants towards
differentiation) and environmental asymmetry (one daughter cell is relocated from the niche)
promt the cell into self-renewal or into a specialised cell-fate [75]. The process of cell division
however stays at the end of a long cascade of signalling events that arise from the varying
stimuli of the niche. Both MSC and HSPC possible share environmental niches, and for the
case of MSC, they are an integral part for the formation of such. The balanced interaction
with the niche thereby controls stem cell quiescence or activation, migration and mobilisation,
as well as differentiation or apoptosis [86].
MSC self-renewal and lineage commitment is regulated via interaction with other cell types,
autocrine or paracrine soluble growth factors and via ECM proteins. In terms of MSC interac-
tion with the ECM, genes have been identified that are involved in regulation of MSC stemness,
which are Thy-1 glycan, decorin and thrombospondin-1 [87]. Furthermore, MSC have been sug-
gested to reside in perivascular niches associated with blood vessels in almost all adult tissues
[68, 88]. As mentioned above, data exist which claim that MSC and pericytes are actually one
and the same cell type, and that virtually all MSC-activity is found within the the pericyte
population [89]. The hypothesis that MSC reside in perivascular niches throughout the whole
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body enhances their capability to migrate to local or distant sites of injury or pathogenesis in
response to systemic signals [64]. However, up to now fairly little is known about the exact
origin of MSC and the detailed regulation of MSC self-reneal within their niches. In contrast
the regulation of HSC by their niche has been studies in far more detail than that of MSC. Two
distinct sites have been suggested and heavily discussed to contribute to HSC niches within the
BM [75, 55, 74], which are the endosteum (endosteal niche) and the region around sinusoids
(vascular niche). Sinusoids are reticular fenestrated venules that allow cells to pass in and out
of circulation. There is evidence that individual dormant HSC are located more in niches at
the endosteum, whereas activated HSCs are in close contact to sinusoids of the BM microvas-
culature [90, 91, 92]. In recent years the term ’niche-stem-cell-synapse’ has been introduced
[75], which describes the close interaction between MSC or differentiated niche osteoblasts with
HSC. Signals that are exchanged through this synapse include cell-cell signals (e.g. N-cadherin
interaction, membrane bound SCF and c-kit receptor interaction, Jagged ligand and Notch re-
ceptor interaction, VCAM1 and VLA4 interaction), MSC secreted signals (e.g. angiopoietin-1,
SDF-1, Wint-ligands) and secreted ECM molecules (e.g. FN-integrin signals, hyaluronic acid
and osteopontin interaction with HSC CD44 glycoprotein receptors). The latest breakthrough
has been presented by a landmark study by Méndez-Ferrer et al. [93]. They have identified
nestin-expressing MSC populations closely associated with HSC. These strictly perivascular
cells are tightly associated with adrenergic nerve fibres and regulate HSC mobilisation. Strik-
ingly, nestin+ MSC expression levels of HSC maintenance factors were higher than those of
any other stromal cell type including osteoblasts. Nestin+ cells show several similarities to so
called CAR cells (MSC progenitors identified as CXCL12-abundant reticular cells), which are
more abundant within the marrow and also show close interaction to HSC [94, 95]. Figure
2.2.2 gives a schematic overview over the locations and components of HSC niches.
Extracellular matrix of the bone marrow niche
Early work in the 1980s by Klein et al. and others have investigated the constituents of BM
ECM [23, 96, 97]. Cytoadhesive components of the BM microenvironment have been identified
and suggested for haematopoietic progenitor regulation, such collagen type-VI, thrombospondin
and tenascin [98, 99, 100]. The close interaction between cells of the BM stroma and HSC have
been studied in vitro using so called Dexter cultures [101]. Dexter et al. introduced this culture
system in the 1970s to culture adherent stroma cells with mixed haematopoietic cell population,
and later with more purified HSC populations. By the help of this culture method various ECM
molecules have been identifed to be secreted by MSC stroma [102, 103]. MSC-secreted GAGs
and proteoglycans play a crucial role for the mainteance of HSC within the niche, either by
direct interaction with HSC, or via the presentation of cytokines to HSC (i. e. control of growth
factor sequestration and establishment of gradients) [104, 105, 106]. Within the last 20 years
our knowledge about BM ECM and its functional role for residing stem cells has dramatically
increased. However, the detailed mechanisms govern maintenance, growth and differentiation
are still largely elusive. The here presented study of the intricate interaction of BM stem
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cells with the broad spectrum of ECM-mediated extracellular signals will add further valuable
informtion to the understanding of MSC and HSC regulation within their microenvironments.
Figure 2.2.2: HSC niches in trabecular bone cavities
Several locations and interactions with environmental cells have been proposed for HSC regulation. HSC can
be found at the endosteum, where they are in contact with osteoblasts that can promote HSC maintenance (the
endosteum can also be remodeled by osteoclasts). Vascular sinusoids are often localised at greater distance to
the endosteal region, where HSC are in contact with perivascular cells. Sinusoids can also be found close to the
endosetum. The assumption that HSC reside in two different niches (the endosteal niche and the perivascular
niche) is still the current concept for HSC niche locations. However, the presence of HSC-promoting nestin+
MSC and CXCL12-abundant reticular (CAR) cells in both locations might indicate that both niches may not
be as distinct as it was assumed. Yet, the osteoblast niche is thought to harbour more dormant HSC and the
perivascular niche houses self-renewing HSC. Graphic adapted from [11].
The need for ex vivo control of bone marrow stem cells in artificial niches
HSC are the one stem cell source that has been successfully used for therapeutic applications
for more than 30 years [107]. Autologous obtained HSC can be used for rescuing the patient
following high doses of chemotherapy or for targeted application of gene-therapy vectors. Allo-
geneic HSC tranplants are useful for the treatment of malignancies by replacing the malignant
haematopoietic system with healthy cells. On top of treating malignancies such as lymphoma,
myeloma and leukaemia by HSC therapy, also other diseases like β-thalasseemia and sickle-cell
anaemia have been successfully treated . Each year approximately 45,000 patients are treated
by HSC transplantation [107]. Present and future therapeutic applications of MSC involve
repair of osteogenic or chondrogenic defects, treatment of graft-versus-host-disease, treatment
of myocardial infarction defects and support of treatments to cure diabetes [60, 69]. The need
for expandable MSC and HSC sources is a pressing issue that urges the development of ex vivo
culture conditions which can support stem cell self-renewing proliferation. The next section
describes stem cell bioengineering approaches, which are aiming at a detailed understaning of
niche regulatory cues for the deconstruction and reconstruction of artificial microenvironments
that support the advancement of regenerative therapies.
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2.3 Stem cell bioengineering - current concepts
The key function of stem cell niches is maintenance of a constant stem cell population during
homeostasis by directed control of stem cell activation or quiescence. Upon injury or disease
stem cells can migrate to other microenvironments or the site of tissue damage and start pro-
liferating and differentiating to regenerate the lost tissue function. However, the mechnisms
by which microenvironmental cues induce this directed behaviour remains poorly understood.
Within their niche, stem cells are exposed to a spatially controlled mix of soluble cytokines
and growth factors (mainly presented via ECM-GAG structures), insoluble receptor ligands
and furthermore fibrillar and adhesion-type ECM proteins. In order to understand the under-
lying mechanisms of stem cell regulation within their niches, several approaches in stem cell
bioengineering are aiming to study isolated components of this complex system. Technologies
such as biomaterials design, microfabrication and microfluidics allow tunable and variable in-
vestigation of influential parameters of stem cell fate, in a systematically manner [15, 16]. Most
stem cell research is carried out on rigid plasma treated polystyrene (tissue culture plastic) sub-
strates. This culture environment is very different from the natural cellular environment of the
body, where the cells are surrounded by a mixture of anchored molecules which are presented
in close proximity and structural complexity. Additionally, gradients of chemokines, calcium
and oxygen have been shown to be involved in the regulation of niche dynamics. One approach
to create improved cell culture conditions is the use of ECM-protein-coated substrates or the
use of cell culture conditions on top of hydrogels which are made from ECM components (for
example Matrigel or collagen gels). Such 2-dimensional (2D) biomaterial culture systems have
the advantage of simplification towards deconstructing the niche. Individual niche components
can be assesed in their effectiveness for controling stem cell fate decisions. On top of this,
other bioengineering approaches are set out to mimic 3-dimensional (3D) conditions as they
are imposed on stem cells within their natural environments. These systems are more complex
and allow instruction of polarised cellular morpholgy and activation of 3D related signalling
events [51, 108]. Taking the engineering approach even further, the use of individual peptide se-
quences or epitopes of ECM molecules is one example of a more reductionist approach to model
basic physicochemical properties of the ECM. Hybrid biomaterials which consist of synthetic
and natural components can make the need of complex ECM materials redundant, but only if
they can accomplish the functional presentation of critical biological cues in a non-natural way
[6, 109].
For the control of bone marrow stem cells within artificial stem cell niches, 2D and 3D bioen-
gineering approaches have been developed to probe individual cues or combinations of cues on
MSC and HSPC self-renewal and differentiation ex vivo.
20
CHAPTER 2. FUNDAMENTALS
Engineered 2-dimensional artificial stem cell niches
Systematic identification and analysis of biomolecules and their relevance for stem cell regula-
tion is one critical step for the definition of niche regulatory factors. Soluble or tethered mo-
lecules have been tested separately or in combination of various patterns and concentrations. In
addition, growth factors and cytokines are usually presented in a spatially immobilised manner
via proteoglycans and receptor ligands are presented via the cell membrane. The immobilisa-
tion of soluble or receptor ligands is proposed to play a critical role for protein stability and
for persistent receptor clustering and signalling [110]. For example, covalent immobilisation of
the Notch1 receptor Delta-1 has been shown to maintain human cord-blood CD133+ HSPC.
Compared to soluble Delta-1, the immobilised receptor resulted in an increase of CD133+
cells that were capable of reconstituting the haematopoietic system of irradiated mice [111].
Similarly, another Notch ligand, Jagged-1, has been shown to expand lineage-negative murine
bone marrow HSPC via immobilisation of Jagged1 on Sepharose beads [112]. In an attempt
to analyse the degree of HSPC adhesion to components of the ECM, Franke et al. have used
immobilised ECM proteins to investigate HSPC adhesion areas. Strongest adhesion was ob-
served on fibronectin surfaces compared to less intense adhesion to heparin, heparan sulfate
or co-fibrills thereof with collagen-I. The separate analysis of each ECM component revealed
integrin α5β1-specific adhesion to fibronectin and selectin-mediated adhesion to heparin [113].
Fibrillar collagen-I matrices have also been used to probe the influence on HSPC mainten-
ance. Collagen-I gel-type substrates enabled HSPC proliferation and such culture conditions
allowed the study of HSPC gene expression profiles in response to this particular ECM com-
ponent [114]. One of the glycosaminoglycans that is most frequently used in biomaterials
approaches is heparin. For example, resorbable polymer scaffolds of polycaprolactone (PGL)
surfaces conjugated with heparin supported high-affinity adsorption of BMP-2 (representing
the cytokine-depot functionality of GAGs) and promoted enhanced adhesion and proliferation
of a murine MSC cell line [115]. Functionalisation of polyethylene glycol (PEG) hydrogels with
heparin was shown to enable sustained viability and osteogenesis of human MSC [116]. Hy-
drogels are favoured materials for bioengineering approaches because of their tunable material
properties, such as hydrogel elasticity. As it was mentioned before, each tissue within the body
has its own tissue-specific elasticity (see figure 2.1.3). A pioneering study by Engler et al.
demonstrated that modulation of polyacrylamide hydrogel stiffness according to the elasticity
of brain, muscle and bone initiated a differentiation process of altered morpholoy and gene
expression of human MSC into the respective tissue-specific cell types [117]. Another example
for stem cell regulation is the manipulation of cell shape via differentially sized adhesion re-
gions. MSC stem cell differentiation was shown to be affectd by differentially-sized patterns of
fibronectin islands. MSC took on the shape of the fibronectin island, either small and round
or large and spread, and in turn were committed towards differentiation into the adipocyte
or orsteoblast fate, respectively [118]. One example of topography-modulated regulation of
umbilical cord CD34+ HSPC was shown by the use of aminated polyethersulfone (PES) nan-
ofibres. HSPC adhered and adopted a spherical morphology to a much greater extend than on
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standard PTP substrates. The biomaterial supported elevated expansion and engraftment po-
tential of CD34+ cells compared to PTP-cultured HSPC [119]. For a more combinatorial and
high-thoughput type of screening of niche regulatory cues array systems have been developed
to test multiple molecules at the same time in parallel. Langer and co-workers have used such
an approach to identify synthetic polymers that can support attachment and proliferation of
MSC [120]. These examples show how the presentation of particular ECM proteins, or the im-
mobilisation of receptor ligands or biomaterial stiffness and substrate topography can influence
stem cell behaviour in a 2D culture setting. These well controlled systems allow the analysis of
minimal sets of niche components. The application of artificial 3D culture scenarios is aiming
at deconstructing a more complex and tissue-like environment.
Engineered 3-dimensional artificial stem cell niches
As mentioned for 2D artificial systems, hydrogels have become a more and more important
biomaterial for the controlled fabrication of stem cell microenvironments. Due to their tunable
properties in terms of physical or chemical cross-linking degree, possible biodegradability and
importantly due to their controllable uptake and delivery of soluble factors, these materials
offer many possiblities for stem cell engineering. However, not all properties (swelling ratio,
mesh size and elasticity) can be modified independently, since they all depend on cross-linking
degree. But, by the use of large scale array platforms, multiple tunable characteristis of the en-
vironment can be investigated. For example, a 3D PEG-hydrogel array system has been used to
screen combinatorial effects on MSC cell behaviour [121]. Out of the investigated parameters,
which were gel degradability, cell adhesion-ligand type and adhesion-ligand denstiy, degrad-
ability and adhesion-ligand density were found to enhance MSC viability in a dose-dependent
manner [121]. Another study by Anderson et al. demonstrated encapsulation of human MSC
in MMP-degradable and cell-adhesive PEG-hydrogels using photopolymerization [122]. MSC
were able to survive and proliferate within these gels, and biodegradability allowed higher ex-
pression levels of differentiation markers (of adipo and osteo lineage progeny) compared to MSC
in non-degradable gels [122]. A similar appraoch using adhesion ligand-modified PEG-RGD
hydrogels has shown that chondrogenic differentiation of encapsulated MSC was enhanced via
a RGD-dose dependent manner [108, 123]. A different 3D-encapsulation approach for MSC
included the fabrication of spherical collagen-I and agarose polymer beads via emulsification
of a liquid MSC-matrix suspensions in a silicone fluid phase and subsequent gelation to form
hydrogel beads. Cell viability could be maintained for 8 days in culture and MSC adhesion
and spreading increased with increasing collagen concentration [124]. Although these encap-
sulation concepts are promising strategies for manipulation of MSC fate and for protected
delivery of stem cells, these systems are limited in terms of effective nutrient and oxygen sup-
ply and removal of cellular waste products. The interwoven fibrous 3D microstructure of stem
cell environments can be mimicked by techniques like electrospinning or self-assembly of nat-
ural and synthetic molecules. Electrospinning allows the deposition of continuous fibres with
high porosity and spatial interconnectivity. For example, biocompatible polymeric electrospun
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fibres fabricated from natrual chitosan have been presented as a sequential BMP-2/BMP-7
(bone morphogenic proteins) delivery system for bone tissue engineering [125]. However, one
disadvantage of electrospinning is the limited variability of fibre diameter, which ranges at the
upper limit of those seen in natural ECM (50-500nm). Microscale mold-based biomaterials are
another way to probe 3-dimensionality in a well-plate or bioreactor sized setting. For example,
fabrication and functionalisation of 10-50μm scale poly(dimethylsiloxane) (PDMS) microcavit-
ies with fibronectin revealed that smaller sized environments promote HSPC-marker expression
and supported a quiescent cellular phenotype [126]. In an approach to model the microscale
sponge-like 3D bone marrow microenvironment in vitro Nichols et al. have used synthetic
silicone scaffolds of inverted colloidal crystal geometry [127], resulting in a microporous envir-
onment that was seeded with a bone marrow stromal cell line. The dimension of the system
allowed 28-day culture of human CD34+ cells within this bone marrow model system. The
haematopoietic cells were able to proliferate and differentiate along the B-lymphocytic lineage.
Although, this system has been able to recapitulate parts of the bone marrow niche, it is not
practicable for use in larger dimensions due the lack of vascular support. A very similar ap-
proach used stromal cell-free 3D inverted colloidal crystal acrylamide hydrogels functionalised
with Delta-1 and was able to support the ex vivo T-cell development of human HSPC [128].
The use of both natural (protein and polysaccharide) and synthetic polymers allowed material
scientists to engineer patterns of adhesion, composition, growth factor gradients, elasticity, de-
gradation rates and geometry. The mechanisms of cellular interaction and subcellular signalling
within these artificial environments still need to be better described and understood [129]. The
field of biomaterial-engineering will continue to investigate particular components of the stem
cell microenvironmental niche, and thereby promote the development of defined regulatory
stem cell systems. However, ultimately it will be desirable to mimic and analyse the role of
comprehensive cellular environments, which would allow the study of a more complete set of
variables. Furthermore, the observed effects in terms of stem cell expansion vary in intensity
and require further optimisation to yield efficient cell numbers for clinical applications. Decel-
lularised natural ECM environments are one possible approach to study the control of stem
cells in a physiologically, topographically and physicochemically more natural 3D environment.
2.4 Decellularisation - creating native ECM environments
Biomaterials and ECM mimicking scaffolds have been shown to enable some degree of con-
structive recreation of tissue properties and ECM functionalities. However, the natural com-
position of the ECM is far more complex than artificial systems are able to imitate. A different
route for the creation of functional ECM scaffolds with intricate compositional and structural
properties is decellularisation of tissues and organs, as well as decellularisation of cell cultures.
Several reasons indicate the superior potential of decellularised ECM systems. ECM molecules
are arranged in a tissue specific and ultrastructural manner and provide an ideal support for
tissue residing cells. To make the situation even more complex, the ECM composition and
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structure is constantly undergoing remodelling by the cells of the environment to procreate the
mechanical demands and the prevailing niche conditions [130]. This dynamic reciprocity is a
major advantage of natural scaffolding material and highlights the imortance of maintaining
appropriate ultrastructure and tissue-specific composition. Native ECM scaffolds that have
been derived from tissues and organs retain many of the tissue intrinsic structures. It has been
suggested that ultrastructural topography together with ligand spacing and alignment of ECM
molecules within decellularised scaffolds provides a defined landscape that directs and supports
appropriate cell attachment and differentiation [131, 132, 133]. These dynamic ultrastructural
characteristics of the natural ECM are important players for modulation of cellular behaviour.
The ECM environment facilitates the cell’s ability to attach and migrate into specific regions
within the scaffold and influences tissue-specific phenotypic differentiation [130]. Decellularisa-
tion of tissues, organs and cell cultures is the most natural way to create ECM environments
that truely resemble the native ECM situation. The most classical approach is decellularisa-
tion of whole tissues and organs to create scaffolds for tissue engineering. Additionally, more
recently also decellularised cell-made matrices in vitro have been investigated for their regu-
latory functions towards stem cells control (see figure 2.4.1). Thus, decellularised matrices are
not only useful for tissue engineering and medical therapy but also for basic biological and
bioengineering research [19].
Figure 2.4.1: Decellularised matrices from tissues/organs and cultured cells
(A) Decellularised matrices from tissues and organs. Native ECM composition, microstructure and biochemical
properties as well as tissue morphology and shape are maintained. (B) Decellularised matrices from cultured
cells. Matrices of cultured cells can mimic the structure and composition of native ECM from different cell
types. Also biomaterial surfaces can be modified with cell-made decellularised matrices. Graphic from [19].
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2.4.1 Decellularisation of tissues and organs
Decellularisation of tissues and organs is one promising approach for generation of highly
functional tissue engineering scaffolds. Such scaffolds provide not only the initial support
of re-seeded cells, they also help migration and localisation of cells towards the appropriate
spaces, combined with optimal physical and biochemical cues for adhesion, proliferation and
differentiation. Following tissue assembly, the propagated cells can remodel the scaffold and
replace the scaffold with their own matrices during the regeneration process. Many studies have
investigated the potential of decellularised tissues and organs as scaffolds for tissue engineering
[19, 134]. A number of human or animal decellularised tissue scaffolds have been created, which
include heart [135] and heart valves [136], blood vessels [137], small intestinal submucosa [138],
lung [133], trachea [139], skin [140], nerve [141], cornea [142], oesophagus [143], liver [144],
kidney [145], bladder [146], cartilage [147], ligament [148], adipose tissue [149] and amniotic
membrane [150]. The intricate vessel and airway network and the 3D organ structure are almost
impossible to reconstruct with conventional technology. Some of these decellularised scaffolds
have already been commercialised for therapeutic applications, such as intenstinal submucosa
and skin-derived products.
As mentioned above, the tissue residing cell population is responsible for the orchestrated ap-
pearance and composition of a tissue specific ECM. Therfore, organ-specific ECM is used to
stimulate cell types that are naturally harboured within the respective environment. Further-
more, decellularised matrices from specific tissues or organs can be utilised in a soluble form
as culture substrate or as injectable gel-type matrices. The advantage is that injectable matrix
mixtures can fit into any 3-dimensional space, instead of using whole constructs of decellu-
larised ECM scaffolds [136]. Furthermore, such extracted and reconstituted ECM mixtures
of decellularised tissue-specific ECM have been shown to support native cellular phenotypes
and cellular functionality, when used as a coating for cell culture substrates [151]. Zhang et
al. demonstrated that skin, liver and muscle specific cell types show better proliferation and
differentiation on substrates that were coated with ECM from their own tissue of origin [151].
Decellularisation techniques
The use of appropriate processing techniques for the purpose of decellularising a tissue or an
organ allows preservation of the native composition, ultrastructure and 3-dimensional archi-
tecture of the derived scaffold. Diverse methods have been developed to remove all cellular
component from an extracellular tissue or organ scaffold [152]. These methods include, phys-
ical, chemical and enzymatic treatments (see figure 2.4.2). Physical treatments use agitation,
sonication, mechanical massage, pressure or freezing and thawing to cause disruption of the
cell membrane and to release intracellular contents. Chemical treatments utilise alkalis, acids,
detergents, organic solvents, chelating agents, hypotonic solutions or hypertonic solutions to
disrupt cell membranes and additionally the bonds that are responsible for intercellular and
extracellular adhesions. Enzymatic treatments use protease or nuclease to cleave peptide or
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nucleotide bonds. All of these methods have their respective advantages and disadvantages. A
trade-off has to be found between efficient removal of cellular remnants such as nuclei, actin
and cell membranes, and the optimal maintenance of biological activity and biomechanical
properties. However, it is extremely difficult to achieve complete decellularisation, and mostly
the remaining ECM material retains some residual DNA and other cytoplasmic and nuclear
material [153]. Especially for fragile scaffolds physical decellularisation methods which dis-
rupt cell membranes via intracellular ice crystals or mechanical cell lysis, are not appropriate
since they can easily disrupt or fracture the ECM architecture. Enzymatic treatments such as
trypsinisation, which cleaves peptide bonds can disrupt ECM structure and remove laminin,
fibronectin, elastin or GAG structures. Chemical treatments utilising Sodium dodecyl sulfate or
Sodium deoxycholate solubilise cytoplasmic and nuclear membranes but also tend to denature
proteins and have been shown to disrupt tissue structure, remove GAGs and damage collagen.
[152]. The method used in this thesis was application of a non-ionic detergent: Triton X-100.
It disrupts lipid–lipid and lipid–protein interactions, while leaving protein–protein interactions
intact. Decellularisation efficiency of Triton X-100 has shown mixed results dependent on the
tissue. Mild effects on GAG removal have also been observed. However, the adverse affects
of these different methods also depend on the exposure time of the respective treatment. In
general, a combination of these methods aims at maximising complete decellularisation while
minimising any adverse effects, and is applied in a selective manner for the tissue of interest
[134]. The same techniques and principles of decellularisation also apply for in vitro-generated
ECM by cultured cells.
Figure 2.4.2: Decellularisation techniques for tissues and organs
Examples of techniques used to decellularise tissues and organs. Abbreviations: CHAPS, 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate; EDTA, ethylene diamine tetraacetic acid; EGTA,
ethylene glycol tetraacetic acid. Graphic adapted from [134].
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2.4.2 Decellularised cell cultures
Three-dimensional decellularised scaffolds of tissues and organs have demonstrated their vast
potential for tissue engineering and medical applications. But for the purpose of in vitro
investigation and manipulation of stem cells and somatic cells, native and multifunctional de-
cellularised ECM culture substrates have become more and more important. Optimal culture
conditions for the purpose of bioengineered stem cell niches should have the capacity to ex-
pand primitive progenitor cells to a maximum amount without changing their phenotype and
characteristics. The special requirements that are demanded of culture scaffolds or substrates
can be supplied by the help of tissue or niche intrinsic cells which secrete and modulate ECM
molecules in a natural way. Along this line, in vivo-like 3-dimensional matrices can be created
that allow the convenient in vitro study of cell-ECM interactions in a physiologically relev-
ant manner and potentially support microenvironmental induced cell morpholgy, function and
signalling.
When cells are kept in culture (usually on tissue culture plastic substrates), they start to
secrete ECM proteins and deposit a layer of structurally and enzymatically processed extra-
cellular material onto the culture carrier [154, 155]. Exploiting this aspect, an ECM-surrogate
substrate can be created in vitro and serve as culture scaffold for re-seeded cell types. Very
early studies by Hedman et al. isolated matrices of human fibroblasts and used them as novel
cell culture substrates [156]. Very complicated ECM structures such as basement membrane
could be recreated by the use of alveolar epithelial cells [157, 158]. Compared to the stand-
ard basement membrane model, which is Matrigel, primary hepatocytes were able to survive
longer and maintain their differentiated functionalities such as albumin secretion at higher
levels when they were cultured on decellularised basement membrane culture substrates [159].
Early studies by Cukierman et al. have demonstrated the difference between cell-matrix ad-
hesions on conventional 2D in vitro substrates and cell-made 3D matrices as they appear in
vivo [160, 161]. By the use of fibroblast cell lines, naturally deposited extracellular matrices
were generated with 3D characteristics. For comparison, cell-matrix adhesion was also probed
on mechanically compressed 2D fibroblast-matrices or more simple 2D ECM substrates such
as laminin or collagen coated surfaces. The observed 3D matrix interactions and adhesions
differed to those of 2D substrate interactions in their content of α5β1 and αvβ3 integrins, pax-
illin, cytoskeletal components and phorsphorilation of FAK [160]. The investigated matrix
adhesions supported in vivo-like cell morphology and cell migration. Differences between clas-
sic in vitro substrates and cell-made 3D substrates indicate the advanced biological relevance
for mimicking living organisms. This highlights again the importance of the above mentioned
ultrastructural topography and ligand spacing landscape of native extracellular matrices.
In an effort to elucidate stem cell regulation and function, cell-made decellularised matrices
have been studied to control stem cells maintenance and directed stem cell differentiation. For
example, embryonic stem cells are usually cultured on a layer of feeder cells to maintain their
pluripotent character. Decellularised matrices prepared from mouse embryonic fibroblasts en-
abled the establishment of human feeder-free cell lines with the ability to maintain self-renewal
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[20]. This indicates the potential of extracellular matrices to instruct a cellular phenotype
and shows that the presence of a cellular feeder-layer is dispensable. On the other hand,
directed stem cell differentiation is another important aspect for the use of embryonic stem
cells for tissue engineering. Higuchi et al. demonstrated that a basement membrane derived
from HEK293 cells (which stably express basement membrane laminin-511) allowed directed
sequential differentiation of mouse embryonic stem cells or induced pluripotent stem cells into
definitive endoderm, pancreatic progenitor cells and finally insulin secreting pancreatic β-cells
[162]. Decellularised matrices have also been used to direct differentiation of adult multipotent
stem cells. As mentioned before, the multipotent character of MSC makes them interesting
candidates for applicatons in bone remodelling and osteogenic therapy. Espcially in the field of
MSC-osteogenesis several groups have tried to utilise the possibilities of decellularised matrices
for the stimulation of osteogenic bone formation. Synthetic biomaterials such as titanium
scaffolds have been surface modified with cell-deposited decellularised matrices. Osteogenic
cell lines and rodent MSC have been cultured on titanium scaffolds coated with decellularised
matrices and have demonstrated enhanced bone formation capacity of these cells [21, 22, 163].
To study the stepwise tissue-development of MSC into the osteogenic or adipgenic lineage,
decellularised matrices were created at each step of the differentiation process [164, 165]. In-
dividually tailored systems like these allow the targeted analysis of stem cell differentiation
processes under natural ECM-microenvironmental conditions. Table 2.4.1 summarises the use
of cell culture-generated decellularised matrices for the investigation and manipulation of so-
matic cells and stem cells.
Table 2.4.1: Cell-made decellularised matrices in vitro
Cell source Application Ref.
Fibroblast Cell culture substrate [155, 156]
Alveolar epithelial cells basement membrane model, cell culture
substrate
[157, 158, 159]
Fibroblast Study of cell-matrix adhesion [160, 161]
Stromagenic fibroblasts Tumor-associated stromal cell cultures [166, 167]
Embryonic fibroblast human embryonic stem cell maintenance [20]
HEK293 differentiation of embryonic stem cells
into pancreatic lineage
[162]
SAOS-2 / osteogenic MSC ECM coating of titanium scaffolds for
osteogenesis of MSC and bone
implantation
[21, 22, 163]
adipogenic/osteogenic MSC matrix preparation at each step of
adipogenesis/osteogenesis
[164, 165]
Table partially adapted from [19].
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The above mentioned studies have all adressed the potential supportive functionality of decel-
lularised cell culture matrices. In particular, these approaches have demonstrated how native
ECM-scaffolds can mimic stem cell niche environments and instruct self-renewal or differenti-
ation in vitro. However, firstly no conceptual strategy has been applied to facilitate biologically
defined and reproducible anchorage of decellularised matrices to the culture carrier, to prevent
delamination processes (upon decellularisation procedure) which hamper the robust genera-
tion of cell-free matrices. Secondly, this lack of reproducibilty has impeded the extensive and
elaborate characterisation of structure and composition of the ECM scaffolds in detail, thus
robust information about the complex interplay of ECM-structure and composition and the
subsequent cell reponse is still missing. Furthermore, so far the use of decellularised culture
substrates as BM niche surrogates for the maintenance of both MSC and HSPC BM stem
cell populations has not been adressed. Based on these facts, the research in this thesis will
adress these issues and work towards the generation of reliably stabilised and reproducible de-
cellularised matrices and towards the establishment of a human primary MSC-generated ECM
substrate that can be analysed in detail for its constituents and for the support of MSC and
HSPC behaviour within their niche. Appreciating the potential supportive functions of other
decellularised in vitro systems, the use of tissue-specific MSC-made niches for the support of
primitive MSC and HSPC cell types is very promising.
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Chapter 3
Materials and Methods
3.1 Surface preparation
The mechanism and procedure for surface immobilisation of reactive copolymers and ECM
molecules has been described in detail by Pompe et al. and Salchert et al. [168, 169, 170, 171].
The techniques that were used in this work for surface immobilisation of polymers and proteins
as well as the procedure for creating decellularised cell-made ECM substrates are described in
the following sections.
3.1.1 Polymer functionalised surfaces
Maleic acid copolymer thin films are a versatile platform for the bio-functionalisation of surfaces
[168]. Within this work the copolymer poly(octadecene alt maleic anhydride) (POMA) was
used. POMA has a molecular weight of 40.000 g/mol, is very hydrophobic (water contact angle
of 100°) and has a thin film thickness of ∼5nm. Covalent attachment of the copolymer to a
planar silicon dioxide substrate was achieved via aminosilane chemistry. The maleic anhydride
moiety can be converted into carboxylic acid groups by hydrolysis in aqueous solution. This
conversion is reversible by annealing the surface at 120°C for 2h. Figure 3.1.1 demonstrates
the coplymer platform and its functionality.
Thin films of POMA (Polysciences Inc., Warrington, PA) were created by spin-coating a
0.16wt% solution in tetrahydrofuran (Fluka, Germany) onto circular glass coverslips (Menzel-
Gläser, Germany), at 4000rpm for 30s. Prior to polymer coating the coverslips were freshly
oxidised in a mixture of aqueous solution of ammonia (Acros Organics, Belgium) and hydrogen
peroxide (Merck, Germany) in a 5:1:1 ratio. To allow covalent binding of the copolymer thin
films, the glass substrates were surface-modified with 3-aminopropyl-triethoxy-silane (ABCR,
Germany) before the copolymer solution was applied. Stable bonding of the polymer to the
glass surface was achieved by annealing at 120°C for 2h. POMA coated coverslips were prepared
in various sizes depending to their later use in tissue culture well-plates.
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Figure 3.1.1: Maleic acid copolymer platform
(A) schematic representation of the maleic acid copolymer platform, covalently immobilised on a silicon
dioxide surface via an aminosilane functionality, (B) maleic anhydride repeating unit and its hydrolysis
in water and the reversible annealing at 120◦C for 2h (schematic adapted from [168])
3.1.2 Immobilisation of bioactive molecules to polymer supports
With the help of the maleic acid copolymer platform it is possible to covalently bind proteins
and other compounds to polymer support surfaces. Figure 3.1.2 shows the mechanism of
binding proteins from solution to annealed maleic anhydride substrates. Proteins bind to the
anhydride moieties of the copolymer via free aminogroups, usually through lysine residues.
Figure 3.1.2: Binding of ECM molecules to POMA-functionalised surfaces
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Fibronectin (FN) (Roche, Germany) was bound to POMA-coated surfaces at a concentration
of 50µg/ml in PBS for 1h at 37°C. FN-POMA surfaces were rinsed in PBS to remove excess FN,
yielding a monolayer of covalently bound FN. Collagen coated surfaces were prepared using
bovine dermal collagen I solution (purified and pepsin-solubilized in 0.012 N HCl, PureCol,
USA) either as fibrillar collagen structures, or as tropocollagen (as described by Lanfer et
al. [172, 173]). For fibrillar collagen substrates collagen was brought to physiological pH
by mixing eight parts of the acidic collagen solution (3.0mg/ml) with one part of 10-fold
concentrated PBS and one part 0.1M NaOH. All components were kept in an ice bath before
and after mixing. Appropriate volumes of chilled 1x PBS were added to adjust the final
concentration of the collagen solution to 1.2mg/ml. The solution was placed onto annealed
POMA-coated coverslips and fibril formation was initiated at 37°C. After 90min the bulk phase
collagen gel was removed from the surface by two PBS washes leaving a thin collagen layer
on the substrate. Tropocollagen surfaces were created by diluting the acidic collagen stock
solution to 0.1mg/ml in 0.012N HCl. This solution was applied to POMA-coated coverslips
and allowed to dry onto the surface over night at room temperature. The next day the surfaces
were washed in PBS twice. Poly-L-lysine polymers (pLL) (Sigma, Germany) can be applied
to make surfaces more adhesive. In this work a 0.01% pLL solution (MW 150.000-300.000)
was covalently attached to POMA-coated surfaces to create a pLL layer for cell and ECM
attachment. The solution was incubated for 1h at 37°C and unbound polymer was rinsed
off by two PBS washes. Matrigel is a processed solubilised mixture of basement membrane,
extracted from Engelbreth-Holm-Swarm mouse tumor, which is rich in ECM proteins. The
major components are laminin, collagen IV and heparan sulfate proteoglycans [174]. Matrigel
was used to compare the MSC-generated ECM with another complex mixture of ECM proteins.
Ice cold Matrigel (BD Biosciences, Germany) was diluted in cold PBS to 50µg/ml to prevent
Matrigel from forming a gel. The solution was incubated on POMA-coated coverslips for 1h at
37°C and subsequently rinsed in PBS yielding a stable Matrigel/POMA surface. Since POMA-
coated surfaces are very hydrophobic the amount of protein solution used was minimised by
simultaneously coating two coverslips in a sandwich-like manner to aid the distribution of the
solution over the whole surface. At the end of the incubation time both coverslips were floated
apart with an excess of PBS and transferred to tissue culture plates in the right orientation.
Bioactively functionalised surfaces were used immediatley or were stored under PBS at 4°C for
up to 48h.
3.1.3 Decellularised extracellular matrix substrates
Decellularised ECM substrates were created in vitro by the use of primary human primary
MSC. The procedure was adapted from a protocol by Beachman et al. [155]. Details on MSC
culture are given in section 3.2.1. First, passage 1 MSC were expanded in 75cm2 culture flasks
to obtain sufficient cell numbers for ECM production. To create cell-secreted ECM layers
passage 2 MSC were plated at 10.000 cells/cm2 onto covalently bound FN/POMA surfaces
and cultured for 24-48h until they have reached confluence. Two different types of ECM were
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created by varying the stimuli subjected to MSC during the ECM secretion phase. Ascorbic
acid was added to the culture to enhance collagen biosynthesis and to stimulate cells to secrete
elevated levels of collagen. This ECM was termed ascorbic acid ECM (aaECM). To mimic the
osteogenic environment of the bone marrow MSC were fed with osteogenic induction medium
(as also described in section 3.2.1). This ECM was termed osteogenic ECM (osteoECM). At
the onset of MSC confluence the medium was changed to either aaECM medium or osteoECM
medium as described in table 3.1.1 (all reagents Sigma, Germany). MSC were allowed to secrete
ECM for 10 days with a medium change every second day.
Table 3.1.1: Media formulations for aaECM and osteoECM production
aaECM osteoECM
50µg/ml ascorbic acid
(280mM)
100nM dexamethasone
10mM ß-glycerol-phosphate
50µM 2-phospho-ascorbic acid
Supplements were added to standard MSC medium (see section 3.2.1)
At day 10 MSC-ECM layers were decellularised with warm PBS pH 7.4 containing 0.5% Triton
X-100 and 20mM ammonium hydroxide (Sigma-Aldrich) by gentle agitation and 2min incuba-
tion at 37°C. ECM layers were washed 3 times with an excessive volume of PBS , whereby care
was taken not to disturb the ECM layer by turbulent PBS flow. ECM substrates were stored
in PBS supplemented with 100U/ml Penicillin and 100µg/ml Streptomycin (Sigma, Germany)
at 4°C for up to 3 months. The quality and integrity of the ECM substrates was verified by
phase contrast microscopy prior to each experiment. For the culture of HSPC on decellularised
ECM, residual cytokines were washed off by a 5s wash in 2M NaCl, 20mM HEPES, pH7.4
containing protease inhibitors (inhibitor mix M, Serva, Germany) to release growth factors
bound via hydrostatic interaction with the ECM (adapted protocol from Reichert et al. [175]).
Quantification of Collagen and sulphated GAG
Total amounts of collagen and sulphated glycosaminoglycans (sGAG) present in decellularised
ECM preparations were quantified using the Sircol collagen assay and Blyscan sGAG assay
(Biocolor, UK), according to the manufacturers instructions (reagents provided by the assay
kit).
Briefly, collagen was extracted from decellularised ECM layers by acid-pepsin solubilisation.
At a pepsin concentration of 0.5mg/ml in 0.5M acetic acid (Sigma, Germany) the enzyme was
effective in removing the terminal non-helical telopeptides to release collagen into solution.
After an over night incubation at 4°C samples were concentrated by first neutralising the
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extracted sample (in Tris-HCl and NaOH) and concentrating all collagen by incubation in
polyethylene glycol in Tris-HCl, pH7.6 at 4°C over night. The centrifuged collagen pellet
was incubated with collagen dye reagent (sirius red in picric acid), which binds to the helical
structures of collagen and forms a collagen-dye-complex that precipitates. After a second
centrifugation step the collagen pellet was washed in ice-cold acid/salt wash-solution (acetic
acid and sodium chloride) and was reconstituted in 0.5M sodium hydroxide to release the bound
dye. Absorbance was measured at 540nm in duplicate using a microplate reader (Tecan GENios,
Tecan Ltd., Switzerland). Sample concentrations were obtained from a collagen standard curve
generated from a collagen type I solution (provided by the assay).
Sulphated GAG were detected in papain extracted decellularised ECM samples. First, ECM
substrates were incubated in papain extraction reagent (0.2M sodium phosphate buffer pH6.4
containing 0.1M sodium acetate, 0.01M Na2EDTA, 0.005M cysteine HCl and 0.2mg/ml papain)
(all Sigma, Germany) at 65°C for 3h to break up the ECM sample. An aliquot of the solubilised
sample was mixed with sGAG dye reagent (1,9-dimethyl-methylene blue) which specifically
binds sulphated polysaccharide components of proteoglycans or the proteins free sulfated GAG
chains. The centrifuged pellet was incubated with dissociation reagent (the sodium salt of the
anionic surfactant) and the dissociated dye was measured spectrophotometrically at 660nm
(Tecan GENios) in duplicate. A reference standard curve was generated from chondroitin
4-sulfate (provided by the assay) which was used to calculate sample sGAG concentrations.
3.2 Cell culture
3.2.1 Mesenchymal stromal cell isolation and culture
MSC were isolated from male human bone marrow (BM) aspirates (donar age 20-40 years),
kindly provided by the University Hospital Carl Gustav Carus, Dresden. Primary MSC were
isolated, expanded and characterised as described previously [176, 177, 178, 179]. The study
was approved by the local institutional review board. Briefly, 5-7 ml BM aspirate was diluted
1:5 in PBS containing 0.5% human serum albumin (HSA) (Sigma, Germany). A 20ml aliquot
was layered over a Percoll solution (d = 1.073g/ml) (Biochrom, Germany) and centrifuged at
900g for 30min at room temperature. Mononuclear cells (MNC) at the interface were recovered
and washed twice in PBS 0.5% HSA. Primary MNC were plated into 75cm2 flasks. Cells were
maintained in a humidified atmosphere of 5% carbon dioxide at 37°C and were cultured in low-
glucose Dulbecco’s modified Eagle medium containing GlutaMAX (DMEM, Gibco, Germany)
supplemented with 10% fetal bovine serum (FBS) (Gibco, Germany) and 100U/ml Penicillin
and 100µg/ml Streptomycin. This medium is referred to as standard MSC medium. Nonadher-
ent cells were removed after 24 hours by a PBS wash. The medium was changed every 3-4 days.
Primary MNCs adherent to tissue culture plastic (one criterium that defines them as MSC [66])
were left to proliferate until they have reached first confluence. Cells were recovered using 0.25%
Trypsin-EDTA (ethylenediaminetetraacetic acid) (Sigma, Germany) and replated at a density
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of 6.000-10.000 cells/cm2 as passage 1 (p1) cells. At this point cells were also cryo-conserved in
standard medium supplemented with 10% dimethylsulfoxid (DMSO) (Sigma, Germany) and
an additional 10% FBS in liquid nitrogen. The initial frequency of colony forming units fibro-
blast (CFU-F) and the cells ability to differentiate into the osteoblast and adipocyte lineage, as
well as surface marker expression of CD (cluster of differentiation) antigens via flow cytometry
(positive for CD166, CD105, CD90, CD73, CD146 and negative for CD34, CD45, CD14) was
evalulated. Isolation of MSC and all initial tests for MSC characterisation were kindly provided
from the Medical Theoretical Centre (MTZ) by the laboratory of Professor Martin Bornhäuser.
All following experiments in this work were performed with passage 1 or 2 MSC.
Proliferation studies
Short term proliferation was measured indirectly via the metabolic activity of MSC using the
alamarBlue proliferation assay (Invitrogen, Germany). In this assay, the reagent resazurin, a
non-fluorescent indicator dye, is converted to bright red–fluorescent resorufin via the reduction
reactions of metabolically active cells. The amount of fluorescence produced is proportional
to the number of living cells. The data were related to a standard curve of defined MSC cell
numbers from 2 independent MSC donor experiments to calculate experimental cell numbers
from fluorescence values (see figure 3.2.1).
Figure 3.2.1: Calibration curve of alamarBlue reduction over MSC cell number
Two different MSC donors were seeded at defined cell densities and reduction of alamarBlue was meas-
ured after cell attachment (dots represent separate values, dashed line represents the average curve). A
non-linear fit (red line) describes the reduction of alamarBlue as a function of cells/cm2.
For long term culture of MSC, cells were cultured on the same substrate for several passages
(up to 10) to determine their proliferation behaviour under constant substrate conditions for
longer periods. At the beginning of each passage cells were seeded at 5.000 cells/cm2. Once
they have reached confluence cells were subcultured to the same starting cell density. At the
end of each passage cell numbers were determined using a Neubauer haemocytometer. Adapted
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from Baxter et al. [180] cummulative population doubling was calculated as follows. Population
doubling within one passage was described as cell number at confluence divided by starting cell
number of the same passage. Cummulative population doubling at each passaging timepoint
was calculated from the population doubling of the given passage added to the population
doublings of the previous passages. Absolute cell numbers (possible yield of total cells, if all
cells were subcultured into the next passage) were calculated from the population doubling
within each passage (percentile growth) mulitplied by the total number of cells at the end of
the previous passage.
Osteogenic and adipogenic differentiation of MSC
MSC differentiation studies were performed as described by Pittenger et al. [181]. Briefly, for
osteogenic differentiation MSC were cultured in standard medium for 2 weeks in the presence of
100nM dexamethasone, 10mM ß-glycerol-phosphate and 50µM 2-phospho-ascorbic acid. Adipo-
genic differentiation was induced by the addition of 1µM dexamethasone, 500µM 3-isobutyl-1-
methylxantine, 100µM Indomethacin and 1µg/ml insulin to standard medium for 2 weeks (all
reagents Sigma-Aldrich). Control cultures recieved no differentiation treatment and were fed
with standard MSC medium. The medium was changed every 2-3 days.
Differentiation intenstiy was quantified by visualising the mineralisation of osteogenic induced
cultures by vanKossa staining as previously described [176]. Briefly, cell layers were fixed
with 10% formalin (Merck, Germany) for 30 minutes, incubated with 2% (w/v) silver nitrate
solution (Sigma, Germany) for 15 min in the dark, and developed with 1% pyrogallol (Merck,
Germany). The layer was washed thoroughly with deionized water and the staining was fixed
in 5% sodiumthiosulfate (Merck, Germany) for 5min. Cultures were imaged by phase contrast
microscopy and mineralisation intensity was analysed using ImageJ software (ImageJ software,
NIH, USA).
Adipogenic differentiation was analysed by Oil Red O staining for fat droplet accumulation
and subsequent extraction and quantification of the dye (adapted from [182]). Cultures were
washed in PBS and fixed in 4% paraformaldehyde, followed by 3 PBS washes. A filtered stock
solution of Oil Red O (Sigma, Germany) at 0.5g/100ml isopropanol was used to prepare the
working solution by dilution with water at a 3:2 ratio. Cells were incubated with the staining
solution for 1h, washed in PBS twice and the walls of the culture wells were cleaned with
PBS soaked cotton buds. After taking photographs for visual evaluation the Oil Red dye was
extracted with isopropanol for 5min and an aliquot was used to measure the absorbance at
540nm with a microplate reader (Tecan GENios, Tecan Ltd., Switzerland).
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Detection of secreted cytokines
The secretory profile of MSC grown on different culture substrates was analysed using (i) a dot
blot cytokine array (Proteome profiler, panel A, R&D Systems, Germany), which allows the
simultaneous detection of up to 21 growth factors and cytokines and (ii) an enzyme linked
immunosorbent assay (ELISA) to quantify secreted cytokine levels of interleukin-8 (IL-8),
angiopoietin-1 (Ang1) and stromal cell-derived factor 1 (SDF1) (Quantikine kit, R&D Sys-
tems, Germany). Three different MSC donors were seeded onto ECM and control substrates at
10.000 cells/cm2 and conditioned medium was collected at 24h, 48h and 72h post plating and
was stored at -80°C. For ELISA quantification of cytokines standard MSC culture medium was
used as a background control. At the same time points as harvesting MSC supernatants re-
duction of alamarBlue was measured to normalise cytokine levels to cell numbers (as described
under MSC proliferation studies, figure 3.2.1).
Cytokine array: For each treatment (substrate) a pool of conditioned supernatants was pre-
pared by mixing the supernatants of 3 different MSC donors, each according to the correspond-
ing volume equivalent to 10.000 cells. This pool of supernatants was mixed with a biotinylated
detection antibody cocktail and applied to nitrocellulose membranes spotted with capture
antibodies to various cytokines. After removal of any unbound material the membrane was
incubated in streptavidin-horseradish peroxidase and a chemiluminescent signal was detected
and imaged using a bioimager (LAS 3000 Bioimager, Fujifilm Life Sciences, USA). The signal
at each spot is proportional to the amount of bound cytokine. Pixel intensity of each spot was
analysed using ImageJ (ImageJ software, NIH, USA).
ELISA: Equal volumes of cell culture supernatant were assayed in parallel for 3 different MSC
donors. Background cytokine levels were assayed in standard MSC medium and in standard
MSC medium in contanct with plain ECM substrates. The amount of cytokine quantified as
pg/ml was then calculated according to the corresponding volume of 10.000 cells (pg/10.000
cells). For this quantitative sandwich enzyme immunoassy, culture supernatants were incubated
on a microplate pre-coated with monoclonal antibody specific for the cytokine of inspection.
Present cytokine in the sample was immobilised to the plate and an enzyme-linked monoclonal
antibody specific to the same cytokine was added. After removal of unbound reagent a substrate
solution was added and a color reaction developed in proportion to the amount of bound
cytokine in the initial step. Optical density was measured using a microplate reader set to
450nm (Tecan GENios, Tecan Ltd., Switzerland). In parallel, a standard curve was generated
from known concentrations of the detected cytokine, from which sample concentrations were
calculated. All standards and all samples were assayed as single measurements.
3.2.2 Hematopoietic stem and progenitor cell isolation and culture
Haematopoietic stem and progenitor cells (HSPC) were isolated from granulocyte-colony stim-
ulating factor (G-CSF) mobilised leukapheresis products obtained from healthy donors after
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their informed consent. Leukapharesis products were provided by the University Hospital Carl
Gustav Carus, Dresden. CD34+ HSPC were selected via magnetic affinity cell sorting (MACS)
using the CD34 direct isolation kit (Miltenyi Biotec, Germany), as schematically shown in fig-
ure 3.2.2.
A small sample volume (2-5ml) of leukapheresis blood was washed by the addition of 8ml isola-
tion buffer (PBS, 2mM EDTA, 0.2% HSA), filtered through a 30μm nylon mesh (pre-separation
filters, Miltenyi Biotec, Germany) to remove coagulated cell clumps and was centrifuged at 300g
for 15min. The upper layer of blood plasma was discarded and the remaining MNC and red
blood cells were resuspended in isolation buffer to a maximum volume of 3ml and processed
for magnetic isolation. Lager sample volumes (6-15ml) of leukapheresis blood were mixed with
ACK lysing buffer (Invitrogen, Germany) in a 1:2 ratio (2ml ACK per 1ml blood) to lyse all
red blood cells. After 5min incubation at room temperature the sample was centrifuged at
300g for 5min and the supernatant was discarded. The remaining pellet of MNC was washed
in 5-10ml of PBS, centrifuged, resuspended in 3-5ml of PBS and processed for subsequent
magentic isolation of CD34+ cells. Prior to magnetic isolation, the sample was incubated with
100μl/108 MNC of FcR blocking reagent (to avoid unspecific labelling of cells via Fc receptors)
and anti-human CD34 antibody (conjugated to 50nm sized magnetic micro beads) for 30min
at 4°C. Samples were subsequently washed by addition of 10ml isolation buffer and were then
separated on a MACS column in a MACS separator which generates a magnetic field that
retains magnetically labelled cells within the column (Miltenyi Biotec, Germany). The flow
through was discarded. After removal of the MACS column from the magnetic field, the re-
tained CD34+ cells were flushed out with isolation buffer and were counted using a Neubauer
haemocytometer. At the beginning of every HSPC culture the purity of the CD34+ population
was verified by flow cytometry to range between 92-99% purity.
Figure 3.2.2: Isolation of CD34+ HSPC from leukapheresis products
Schematic representation of the isolation of HSPC from G-CSF-mobilised leuapheresis products by
magnetic affinity cell sorting (MACS). HSPC are enriched via immunolabeling of the CD34 surface
antigen with magnetic bead-conjugated antibodies.
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Isolated HSPC were cultured in suspension in serum-free CellGro medium (CellGenix, Ger-
many) supplemented with 10ng/ml human stem cell factor (SCF) (Miltenyi Biotec), throm-
bopoietin (TPO) and FMS-like tyrosine kinase 3 ligand (Flt-3) (both R&D Systems). For
standard culture experiments a cell density of 50.000-60.000 cells/2ml were plated to 9cm2
culture wells. Cells were kept in culture for one week without a medium change. At the end
of culture (on ECM or control substrates) cells were harvested from the culture carrier by 2
washes with PBS, a 10min incubation in accutase (PAA, Germany) followed by a final wash in
PBS. All cells from each washing step were collected in one tube and centrifuged at 300g for
5min. Cells were resuspended in a defined volume of PBS to allow quantification of total cell
numbers and were kept at 4°C until proceeding with subsequent flow cytometry analysis.
Flow Cytometry
Freshly isolated HSPC and in vitro expanded cells were analysed for their cell surface marker
expression (CD-antigens) by flow cytometry using the MACSQuant Analyser (Miltenyi Biotec,
Germany). Cells were prepared for flow cytometric analysis by 15min incubation at 4°C in PBS
containing FcR blocking reagent at a 1:11 dilution, 2mM EDTA and 5% BSA. Samples were
split into defined volumes for various staining cocktails. To calculate absolute cell numbers of
cell expansion after in vitro culture it was crucial to define the volume of intial cell suspension
used for the final flow cytometric analysis of a given flow cytometry sample volume. Cells were
labelled with up to 3 antibodies (with APC, PE and VioBlue label) at a 1:11 dilution in PBS
containing 2mM EDTA and 1% BSA, for 10min at 4°C and were subsequently washed in the
same buffer, centrifuged at 300g for 5min and resuspended to a final volume for flow cytometric
analysis. To account for unspecific antibody binding to the cell surface control samples were
labelled with isotype-control antibodies conjugated to the same fluorophore as the staining
antibody. Just before sample measurement, propidium iodide (Miltenyi Biotec, Germany) was
added at a 1:100 dilution to exclude all dead cells from the analysis. A list of all antibodies
used for flow cytometry is given in table 3.2.1. Data were analysed and processed using FlowJo
(FlowJo software, Tree Star Inc., USA).
Table 3.2.1: Flow cytometry antibodies
antibody isotype / clone dilution company
CD34-magnetic micro beads IgG1 (Qbend/10) 1:11 Miltenyi Biotec
CD34-APC / PE IgG2a (AC136) 1:11 "
CD133-PE / APC IgG2b 1:11 "
CD45-VioBlue IgG2a 1:11 "
CD117-PE IgG1 1:11 "
isotype-APC / PE IgG2a 1:11 "
isotype-APC / PE / VioBlue IgG2b 1:11 "
isotype-PE IgG1 1:11 "
allophycocyanin (APC), phycoerythrin (PE)
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For the analysis of HSPC expansion on ECM or control substrates, the accurate starting cell
number of CD45, CD34 and CD117 cells was calculated from the flow cytometric measurement
of freshly isolated cells (related to 60.000 cells that were subjected to each substrate). At the
end of culture, the total cell number harvested from the surface was determined and CD45,
CD34 and CD117 cells were calculated from the flow cytometric measurement. CD45 was used
as a marker for total haematopoietic cell number. The fold change (expansion/decrease) in cell
number was then related to that of the PTP control substrate within each experiment.
3.3 Proteomic analysis of extracellular matrices
To characterise the constituents of MSC-generated decellularised ECM substrates a proteomic
approach was chosen. Via mass spectrometric analysis of fractionated protein extracts proteins
present in aaECM and osteoECM substrates were identified.
3.3.1 Protein extraction
Decellularised ECM substrates were generated as described in section 3.1.3. Before decel-
lularised matrices were processed for protein extraction, the presence of residual DNA was
minimised by a DNase treatment. A 9cm2 area of ECM substrate was treated with 1ml DNase
buffer (50mM Tris-HCl, 10mM MgCl2, 0.05mg/ml HSA and 50U/ml DNase I) (all Sigma,
DNase I Roche, Germany) followed by two PBS washing steps. Proteins of the ECM were then
extracted in 400μl 5M guanidine buffer containing 10mM dithiothreitol (DTT) (both Sigma,
Germany) and protease inhibitors (protease inhibitor mix M, Serva, Germany) at 4°C over
night on a rocking platform. The next day the solubilised ECM was scraped off the culture
well and ECM extracts of 5 different MSC donors were pooled together, for aaECM and os-
teoECM respectively, yielding a final volume of approximately 12ml. These extracts were left
to solubilise further for 3h at 4°C, rotating. Samples were mechanically homogenised using
an Ultra-Turrax (Ultra-Turrax T8, IKA-Werke, Germany) at level 6, followed by a 2h incub-
ation step at 4°C, rotating. To lower the high salt concentration of the extraction buffer in
the sample, a buffer exchange was performed using cellulose membrane spin columns with an
exclusion size of 3kDa (AmiconUltra-4, MilliPore, Germany) against tissue protein extraction
buffer (T-PER buffer, Pierce, USA) containing 25mM Bicine, 150mM sodium chloride and de-
tergent at pH7.6 which was supplemented with 20mM ß-mercaptoethanol (Sigma, Germany).
First, the membrane was wetted with T-PER buffer via centrifugation at 4000g at 4°C. The
total amount of protein extract was added to the column by serial centrifugation steps. Large
sample volumes were split to up to 3 cellulose membrane spin columns and were combined at
the end of the buffer exchange. The protein in each spin column was washed at least 3 times
with 2ml T-PER buffer via centrifugation. Samples were concentrated to a final volume of
500μl in T-PER buffer. At this point protein extracts were aliquoted to appropriate volumes
and frozen at -80°C.
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3.3.2 Protein separation and mass spectrometry
The protein concentration of the ECM extract was determined via Bradford assay (Coomassie
solution, Sigma, Germany) and the equivalent volume of 7µg protein was precipitated with
4 volumes of ice-cold aceton (Sigma, Germany) at -20°C for 2hr. A pellet was obtained by
centrifugation at 18.000g and was dissolved in 20μl of 4x sample buffer (0.25M Tris-HCl, 6%
SDS, 40% glycerol, 0.04% bromphenolblue, 20% β-marcaptoethanol). Samples were separated
by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on 1mm thick,
7% acrylamide gels at 120V. Protein bands were visualised by coomassie brilliant blue stain
(Coomassie G-250, Sigma, Germany). The procedure of SDS-PAGE separation was carried
out following standard protocols by U.K. Laemmli [183]. SDS-PAGE gels were imaged using
the LAS 3000 Bioimager (Fujifilm Life Sciences, USA) prior to subsequent processing for mass
spectrometry.
All mass spectrometric analysis were done at the Mass Spectrometry Facility at the Biotech-
nology Center (Technical University, Dresden) in collaboration with Chrsitian Niehage and
Bernard Hoflack. The following methodical description was contributed by Christian Niehage.
SDS-PAGE separated extracts of aaECM and osteoECM were cut into 17-20 slices according
to the major bands present in both lanes. In-gel digestion of proteins was performed using
standard protocols [Shevchenko 2006]. Briefly, proteins were reduced by 10mM dithiothreitol
and carbamidomethylated by 55mM iodoacetamide. Tryptic digestion was performed in an
enzyme to protein ratio of 1:20 for 16h at 37°C. Peptides were eluted, dried and resuspended
in 20µL 0.1% formic acid. LC-MS analysis were performed on an Ultimate 3000 HPLC system
(Dionex, Amsterdam, The Netherlands) in front of a LTQ Orbitrap XL mass spectrometer
(Thermo Scientific, Bremen, Germany), equipped with a nanoESI source (Proxeon, Odense,
Denmark). 9µL of each peptide fraction was loaded onto a precolumn (C18, 2cm x 75µm, 3µm
beads of 100Å pore size , Dionex) and separated on a 50cm column (C18, 50cm x 75µm, 2µm
beads of 100Å pore size , Dionex) using a 240min linear gradient from 5% to 45% acetonitrile
containing 0.1% formic acid. Top 8 peaks in mass spectra (Orbitrap, resolution 60000) were se-
lected for fragmentation (CID, normalized collision energy 35%, activation time 30ms, q-value
0.25). Dynamic exclusion was enabled (repeat count 2, repeat duration 10s, exclusion duration
20s). MS/MS-spectra were acquired in the LTQ in centroid mode. Proteins were identified
using the MaxQuant software package version 1.2.0.18 (MPI for Biochemistry Munich, Ger-
many) [Cox 2008] and Uniprot data base version 02/2011. Carbamidomethylation of cysteine
was chosen as a fixed modification, acetylation of the N-terminus, deamidation of asparagine
and oxidation of methionine as variable modifications. Other parameters were: a protein FDR
of 0.01, a minimum of unique peptides of 1 and a minimum of two different peptides for each
protein.
42
CHAPTER 3. MATERIALS AND METHODS
3.4 Microscopy techniques
Bright field, phase contrast and and fluorescence microscopy
For standard analysis of cell cultures and for the examination of decellularised ECM substrates
a Leica inverted microscope (Leica DMIL, Leica Microsystems, Germany) in combination with
Leica application suite (LAS software, Leica Microsystems, Germany) was used. All images
of cell cultures and decellularised ECM are greyscale phase contrast micrographs. Bright field
images were taken for visualisation of MSC differentiation (Oil Red O and van Kossa stain)
and for color images of histological stainings of bone marrow specimen.
Histology of paraffin-embedded bone marrow cylinders
Human bone marrow was anlaysed using biopsy material of the iliac crest from bone marrow
aspirations (same as for MSC isolation, see section 3.2.1 and figure 3.4.1). A cylinder of trabec-
ular bone was collected from the aspiration needle and immediately fixed in 10% formaldehyde
(neutral buffered formalin, Sigma, Germany) for approximately 24h at room temperature. For
better sectioning results of the hard bone specimen the samples were decalcified in 10% formic
acid and 5% formaldehyde (Sigma, Germany) for 6h at room temperature. Samples were
washed in distilled water and placed back into fixation solution until processed for paraffin
embedding (within the same day). All subsequent embedding and histological staining pro-
cedures were performed by the Pathology department of the Universty Hospital Carl Gustav
Carus, Dresden. Briefly, samples were dehydrated and infiltrated with paraffin, followed by
sectioning of 1μm sections. Paraffin sections were deparaffinised and either immunostained for
CD34 using a brown DAB (diaminobenzidin) color reaction to visualise CD34 expression or
were stained by standard histological techniques, such as haematoxylin/eosin staining (visu-
alising nuclear, cytoplasmic and collagenious structures) and alcian blue staining (visualising
suflated glycosaminoglycans).
Figure 3.4.1: Preparation of bone marrow cylinders for ulstrastructural and histological analysis
(A) Human bone marrow specimen were collected as cylinders from the bone marrow aspiration needle. (B) Bone
marrow cylinders were fixed in glutaraldehyde for electron microscopy or in formalin for histological analysis.
(C) Epoxy embedded cylinders for ultra-thin sections (200nm). (D) Decalcified and paraffin embedded cylinders
for micro-thin sections (1μm).
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Immunocytochemistry for cell shape analysis
Cell shape of MSC was determined by fluorescence imaging of phalloidin stained cells to visu-
alise the cellular cytoskeleton. To analyse cell shape during the initial contact with the various
culture substrates MSC were plated at a starting density of 2.000 cells/cm2. After 48h cultures
were washed in PBS and fixed in 2% paraformaldehyde (Sigma, Germany) in PBS. Cell mem-
branes were permeabilised in PBS containing 0.2% Triton X-100 (Sigma, Germany) followed by
a 1h incubation with phalloidin-Alexa 488 (molecular probes, Invitrogen, Germany). Samples
were washed in PBS twice and mounted onto micoscope slides. Fluorescently labelled cells were
imaged using the Leica DMIRE2 fluorescence microscope (Leica Microsystems, Germany). At
least 10 images of each substrate were taken and cell shape was analysed from a minimum of 50
cells, using ImageJ (ImageJ software, NIH, USA). Cell shape was determined as cellular area in
μm2 and as cellular roundness (whereby 1 describes a perfect circle, roundness = 4·area
pi·√majoraxis ).
Scanning Electron Mircoscopy
Morphological characterisation of decellularised ECM substrates
The morphological characteristics of decellularised ECM substrates were analysed by scanning
electron microscopy (SEM). To maintain the complex structure of the ECM and the attached
GAGs, a fixation procedure was adapted from Wight et al. [105]. Ruthenium red is a cationic
dye that allows superior visualisation of proteoglycans in combination with a post-fixation in
osmiumtetroxide [184]. ECM substrates were washed in PBS and fixed in 0.1M cacodylate
buffer pH 7.3 containing 2% paraformaldehyde, 2% glutaraldehyde and 0.2% ruthenium red
for 1h at room temperature. Samples were rinsed for 30min in 0.1M cacodylate buffer contain-
ing 7.5% sucrose and 0.1% ruthenium red followed by postfixation in 0.1M cacodylate buffer
containing 1% osmiumtetroxide and 0.05% ruthenium red (all reagents Sigma, Germany; OsO4
by Roth, Germany). Next, the samples were washed in double distilled water and critical point
dried (Bal-Tec CPD 030, Bal-Tec, Liechtenstein), sputtered with 3nm platinum (Bal-Tec SCD
500, Bal-Tec, Liechtenstein) and examined using a Zeiss scanning electron mircroscope (Zeiss,
Ultra Plus, Zeiss Germany).
Ultrastructure of human bone marrow
Bone marrow cylinders have a also been used to analyse the in vivo ultrastructure of stem
cell microenvironments. Bone marrow specimen were collected as decribed for histological
analysis (see figure 3.4.1). Following the collection of the bone marrow cylinder the samples
were fixed in 2% glutaraldehyde in PBS for 24h at room temperature. After a PBS wash
the samples underwent an over night post-fixation procedure in 2% osmiumtetroxide (Roth,
Germany) to improve image contrast of fatty substances and membrane structures. Samples
were dehydrated in increasing concentrations of acetone. At 50% aceton concentration the
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samples were again negative stained in 1% uranylacetate (Sigma, Germany) to further add to
the contrasting effect of OsO4 for enhanced electron-scattering. After 3 cycles in 100% acetone
and total dehydration the samples were embedded in epoxy resin using the modified SPURR
embedding kit (Serva, Germany). After curing the resin over night the samples were trimmed
and sectioned to ultra-thin sections (200nm) using a Leica ultramicrotome (Leica EM UC7,
Leica Germany).
Transmission electron microscopy (TEM) was performed by the electron microscopy facilty of
the Max Planck Institute of Cell Biology and Genetics, Dresden. Prior to microscopical analysis
the samples were again stained in uranyl acetate and lead cytrate. Bone marrow regions close
to the bone surface of trabecular bone were analysed for cellular distribution of stromal cells
and presence of extracellular structures.
Atomic force microscopy
Atomic force microscopy (AFM) was used to analyse the elasticity and the thickness of de-
cellularised ECM substrates. Samples were prepared for AFM analyis by DNase treatment to
remove excess adhesive matieral that could interfere with the interaction of the AFM-cantilever
with the surface (see DNase treatment as described in section 3.3.1). All AFM measurements
were performed by Jens Friedrichs using a Nanowizard II AFM (JPK Instruments) mounted on
an inverted optical microscope (Observer.D1, Zeiss). For elasticity and height measurements,
tipples, 200 µm long V-shaped cantilever having nominal spring constant of 0.06N/m (NP-O,
Bruker) were used. Cantilever were calibrated using the equipartition theorem [Hutter, 1993].
For elasticity measurements, colloidal force probes were prepared by attaching glass beads
(diameter 20 µm, Kisker Biotech) to the apex of tipless cantilever using a two-component
epoxy glue (Araldit) as described [185]. To prevent non-specific adhesion to the matrices, the
modified cantilevers were incubated in heat inactivated fetal calf serum (Invitrogen) for 1 hour
prior to cell elasticity measurements. Force-distance curves were acquired using 500pN contact
force and 5µm/s approach/retract velocity. The Young’s Modulus was extracted from approach
force-distance curves using the AFM data processing software (JPK Instruments).
To measure the thickness of hydrated ECM substrates a defined scratch was applied to the
substrate to analyse the difference in height over the scratch area. To create a defined scratch
ECM substrates were first dehydrated under a laminar flow of nitrogen after 3 washes in double
distilled water. Using a scalpel a straight scratch was drawn into the decellularised ECM. The
substrate was rehydrated in PBS and processed for AFM measurement. The height of the
matrices was determined by performing a 100µm line scan perpendicular to the scratch. Scan
velocity was 1µm/s.
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Statistical analysis
Data were analysed using GraphPad Prism 5 (GraphPad Software Inc., USA). Multiple samples
were analysed by one-way analysis of variance (ANOVA) and Tukey-Kramer’s post hoc test or
by two-way ANOVA and Bonferroni post hoc test to evaluate statistical differences among all
samples. Asterisk denote statistical significance as follows: *P<0.05, **P<0.01, ***P<0.001.
All data are presented as mean values ± standard error of mean (s.e.m.).
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Results and Discussion
This study was set out to mimic the natural microenvironment of the BM in terms of ECM
composition and architecture, to facilitate improved culture and expansion of stem and pro-
genitor cells outside the human body. Therefore, at the beginning of this project the in vivo
architecture of human BM was investigated to gain insight into the arrangement of ECM mo-
lecules within BM microenvironments. Next, the establishment of a stable anchorage platform
for reproducible attachment of MSC-secreted matrix molecules is presented and complemented
by varying stimulation of MSC during the ECM segregation phase. The established matrix
substrates were further analysed for their morphology, topography, elasticity and composition.
Finally, the potential for progenitor cell support and expansion was investigated by MSC and
HSPC culture in contact with decellularised matrices.
4.1 Human bone marrow analysis
Trephine BM biopsy specimen from the iliac crest (drawn from the aspiration needle after BM
aspiration) were used to study the histological and ultrastructural appearance of human BM.
The focus was to analyse ECM structures present at BM sites which are thought to be stem
cell niches, for example the osteogenic niche at the trabecular bone surface [75]. All samples
were obtained from healthy donors and the overall appearance of the analysed BM specimen
was in line with the common knowledge of trabecular bone anatomy. The haematopoietic BM
depicted a highly vascularised reticular connective tissue, densly packed with haematopoietic
cells [186]. The haematopoietic cell content relative to adipocyte content was in a normal range
between 40-60% [58]. The bone surface was covered by endosteal cells, usually osteoblasts and
stromal cells which secrete collagenous matrix into their environment [23]. This layer of matrix
is called the osteoid, which gradually mineralises and forms the solid bone [187]. Figure 4.1.1 A
and B shows transmission electron micrographs of bone lining regions. The analysed specimen
were not decalcified and show a clear boundary between dark and mineralised bone areas and
lightly coloured areas of osteoid (adjacent to osteoblasts). However, the specimen showed
intrinsic artefacts of ruptured cells and cellular debris, caused by the aspiration and sampling
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proceudure. It was therefore difficult to analyse intact haematopoietic cells in close contact
with the endosteal niche. Yet, it was clearly detectable that stromal cells secrete large volumes
of extracellular material into their environments. Figure 4.1.1 C and D shows an osteblast cell
that secreted large amounts of collagen into the extracellular space, whereby typical patterns
of collagen fibrils are visible either as longitudinal fibrils or in cross-section [188].
Figure 4.1.1: Human bone marrow ultrastructure
Transmission electron micrographs of human bone marrow specimen. Images show the accumulation of matrix
material along the bone surface. Osteoblasts and bone lining stroma cells secrete collagenous matrix into their
environment. Hematopoietic cells reside within the marrow space. (b bone, os osteooid, ob osteoblast/bone lining
cell, ms marrow space, e erythrocytes, coll collagenous matrix) Scale bars at 5μm (A-C) and 2μm (D).
The marrow space provides the framework for nutritional supply and waste removal via the
vascular network. Self-renewal and and differentiation of precursor cells is provided by the
marrow stroma [58]. BM stroma is known to be a mixture of adipocytes, fibroblasts and
macrophage-like cells, as reviewed by Campbell et al. in 1988 [189]. Pioneering work in
the 1980s has identified many ECM components of the bone marrow environment [96, 97,
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190], including fibronectin, collagens and proteoglycans. The histological analysis of paraffin
embedded samples allowed a general overwiew of the trabecular and vascular architecture of
human BM. The paraffin specimen were also slightly damaged at the interface between bone
and marrow, caused by the sectioning procedure. Figure 4.1.2 shows CD34+ cells that were
detected at endosteal (panel A-D) and medullary (panel E-H) sites of the BM. Their phenotype
shows a small cell shape with a low nuclear to cytoplasmic ratio.
Figure 4.1.2: Human bone marrow histology
Paraffin sections of human bone cylinders from bone marrow aspirations. (A-H) Immunohistochemical staining
for CD34 cell surface antigen (brown DAB-signal). (I-L) Haematoxylin/Eosin cytoplasmic and nuclear staining.
Blue color depicts nuclei, red color depicts cytoplasm and collagenous fibres, faint red depicts elastic fibres. (M-
P) Alcian blue staining for sulfated gylcosaminoglycans in blue. (v vessel, b bone, f fat, arrow CD34+ cells,
arrow head alcian blue positive areas, dotted line marks the bone surface). Scale bar at 50μm.
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Endothelial cells, also expressing CD34 mark the vasculature within the BM. The localisation
of CD34+ HSPC was in line with proposed stem cell niches, like the osteoblastic niche [92], the
reticular stromal niche [68] and the vascular endothelial niche [91]. Haematoxylin and eosin
are basic and acidic dyes for the visualisation of nuclei and cytoplasm, respectively. Eosin also
stains collagen and elastic fibres. Panel I-K shows densly packed haematopoietic cells in the
marrow space surrounded by collagenous matrix material. Image L shows an expample of a
blood vessel next to the bone surface. The area around the vessel is supported by elastic and
collagenous fibres. Alcian blue is a positively charged dye that binds to anionic substances like
sulfated glycosaminoglycans (GAG). Panel M-P shows accumulation of GAG molecules at the
bone interface. Very little glcoprotein staining was observed in the marrow space, which might
be due to the processing of the sample material.
Histological and ultrastructural analysis have shown that the endosteal region in human BM
harbours ECM proteins and proteoglycans. The existing ECM components are in exchange
with progenitor cells by cell-ECM interactions. To mimic these interactions in vitro an au-
thentic surrogate system has to be developed. Since stromal cells from the BM produce large
amounts of ECM the idea was to use these cells and allow them to secrete BM-like ECM mi-
croenvironments outside the human body. The next section will discuss the establishment of
stromal cell-generated ECM systems.
4.2 Stromal cell-generated decellularised matrices
As observed by the analysis of human BM specimen, the ECM of living organisms is organised
in a three-dimensional and fibrillar pattern. In order to allow better culture conditions for BM
stem cells it is vital to provide the right microenvironment for cell adhesion, migration and
proliferation. Previous studies by Cukierman et al. have shown the potential of 3-dimensional
matrices in creating physiologically relevant cell-matrix interactions [160]. To create culture
substrates that are able to closely mimic the complex nature of the in vivo situation primary
human BM-MSC were used to generate extracellular matrices in vitro. The generation of 3-D
matrices was adapted from a protocol by Beacham et al., which utilised primary fibroblast
for the production of ECM substrates [155]. However, the main problem was the stabilisation
of the secreted ECM to the culture substrate. The next section describes the stabilisation of
MSC-secreted ECM to culture carriers.
4.2.1 Stabilisation of MSC-secreted ECM
To establish an in vitro ECM niche, early passage (p2) human MSC were allowed to deposit
ECM onto the culture carrier for a period of 10 days. Subsequently, the cellular MSC layer was
withdrawn from the culture by a decellularisation procedure using a detergent buffer containing
Triton X-100 and ammonium hydroxide. Cultures were in short contact with the decellular-
isation agents and little mechanical force was applied to dislodge the MSC. The aim was to
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cause minimal disruption to the underlying ECM network with tethered glycoprotein struc-
tures. However, the major drawback at that point was the delamination of freshly generated
decellularised ECM sheets from the culture surface. The top panel of figure 4.2.1 shows the con-
fluent MSC layer and the decellularised ECM network on standard polystyrene tissue culture
plastic (PTP) substrates. The necessary washing steps to remove remnant cellular debris and
the decellularisation reagent caused substantial displacement of the ECM layer. Beacham and
colleagues described in their decellularisation protocol a procedure of surface preparation that
includes gelatin coating and cross-linking of gelatin with glutaraldehyde to stabilise the attach-
ment of marices [155]. However, the artificial cross-linking of gelatin might hamper the natural
interaction of ECM molecules with the surface and weakens the flexibility of the cell-generated
ECM environment. Therefore, a dedicated approach was developed to improve interaction and
anchorage of the secreted ECM with the culture surface. Reactive maleic-anhydride copolymer
thin films aid the adhesive interaction between ECM and the substrate (see section 3.1.2 and
[168]). Thin films of the hydrophobic polymer poly(ocadecene-alt-maleic anhydride) (POMA)
were applied onto glass coverslips, and allowed covalent binding of biomolecules to anhydride
moieties of the polymer via free aminogroups of the protein (usually by lysine residues). Co-
valently bound tropocollagen, fibrillar collagen, poly-L-lysine (pLL) and fibronectin (FN) was
used to study which biomolecule serves best as a coupling agent to stabilise the secreted ECM
sheets. Figure 4.2.1 shows culture of BM-MSC on each tested substrate and their effectiveness
in stabilising decellularised ECM layers. All substrates showed decreased delamination effects
during the decellularisation and washing procedure compared to PTP substrates. Tropocolla-
gen and fibrillar collagen surfaces exhibited a thick underlying sheet of globular and fibrillar
collagen, respectively [170]. Both substrates were rated as not applicable for routine stabilisa-
tion of MSC-generated ECM. Not only is tropocollagen the least effective in stabilising intact
ECM layers (out of the 4 tested biomolecules), but also the artificial gel-like layer of fibrillar
collagen appears to engage a large part of the decellularised ECM network instead of serving
as a thin link between ECM and the substrate. The hydrophilic poly-L-lysine is a positively
charged homo-polypeptide that is thought to mediate electrostatic binding of adhesion ligands
to the surface. pLL was effective in stabilising ECM layers, however it did not support effi-
cient stabilisation over longer storage periods. Thin monolayers of FN (at a concentration of
400ng/cm2, [191]) showed superior ECM adhesion and anchorage to the substrate and preven-
ted ECM perturbation during cell lysis. The remaining ECM layer appeared as a homogenious
and dense sheet of complex interconnected ECM structures. The FN molecule serves as a
protein-binding platform via its functional binding domains (FN domain type I, II and III)
that are responsible for binding to fibrin, collagen and heparan sulphate proteoglycans [29, 34].
Multiple interactions sites between FN and secreted ECM molecules enhance the stability of
the substrate and maintain a natural conformation of the matrix network. Since covalently
bound POMA/FN surfaces resulted in the best stabilisation of decellularised matrices they
were used for all following experiments as an anchorage platform for ECM substrates.
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Figure 4.2.1: Substrates for stabilisation of secreted ECM to the culture carrier
Different substrates tested for stabilisation of secreted ECM. Almost complete delamination of decellularised ECM
layers from PTP culture carriers (top row). Tropocollagen, fibrillar collagen, poly-L-lysine (pLL) and fibronectin
were covalently bound to POMA-coated surfaces to probe their stabilisation properties. Left column shows cells at
confluence prior to the decellularisation procedure. Right column shows the cell-free ECM sheets after extensive
washing in PBS. POMA-fribronectin was found to anchor the decellularised ECM most appropriate (dotted box).
Images are phase contrast micrographs, scale bars at 100μm.
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To account for the different regions of BM two kinds of ECM were generated, by applying dif-
ferent stimuli to the cells during the ECM production phase. The first kind of ECM substrate
was created focussing on enhanced collagen secretion by BM-MSC. Collagen sythesis is de-
pendent on the presence of vitamin C. For the conversion of procollagen into collagen, namely
the hydroxylation of proline and lysine residues, ascorbic acid is needed as a cofactor [192].
Therefore, ascorbic acid effectively augments collagen biosynthesis [193]. The ECM substrates
that were created by elevated ascorbic acid supplementation were termed aaECM. The second
type of ECM that was generated by BM-MSC was thought to mimic the osteogenic microen-
vironment, similar to the endosteal region that is created by bone lining osteoblasts [74]. To
induce MSC differentiation into osteoblasts and to trigger the secretion of osteoblast-like ECM
molecules, the cultures were supplemented with osteogenic induction factors (see table 3.1.1).
The ECM substrates that were created by osteoblast differentiated MSC were termed os-
teoECM. Figure 4.2.2 shows the confluent MSC layers and the decellularised ECM of both
ECM types. Morphologically, both types appeared as very complex interwoven networks of
ECM proteins, fibres and GAGs. OsteoECM appeared less dense and showed an open comb-
like structure resembling the arrangement of osteogenic induced MSC. In comparison, the
appearance of aaECM was specified by the aligned morphology of the confluent MSC-layer and
resulted in a thick and packed matrix environment left behind after decellularisation.
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Figure 4.2.2: aaECM and osteoECM stabilised on FN/POMA culture carriers
Two types of ECM substrates were generated by MSC stimulated with ascorbic acid (aaECM) or osteogenic
induction media (osteoECM). MSC were cultured on FN/POMA carriers until confluence and allowed to secrete
ECM for 10 days (top row). An anchored protein network was acheived throughout the decellularisation process
yielding stable ECM substrates with distinc morphology for aaECM and osteoECM, respectively (bottom row).
Images are phase contrast micrographs, scale bars at 100μm.
In summary, the procedure of creating decellularised ECM substrates has been optimised in
terms of stability and variety. The application of continuous covalent attachment of coupling
agents such as aminosilane, a hydrophobic reactive copolymer thin film and fibronectin permits
reproducible and robust anchorage of ECM proteins to the culture surface. The idea of using
BM intrinsic cells to generate ECM microenvironments was successfully conducted and resulted
in the establishment of two varying types of MSC-made ECM that can serve as cell-free in vitro
niches. These substrates were furthermore analysed for their characteristics, as discussed in
the next section.
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4.2.2 Characteristics of decellularised matrices
MSC-generated decellularised extracellular matrices were analysed for their ultrastructural
appearance, their physical properties and for abundance of collagenous and sulphated glycosa-
minoglycan components. First, the ultrastructural character was anlysed via scannig electron
microscopy (SEM). The most striking observation when looking at decellularised matrices,
is their complex architecture and fibrillar interwoven disposition. Figure 4.2.3 shows SEM
micrographs of aaECM and osteoECM substrates. Both matrices have a distinct morphology.
aaECM substrates depict a dense meshwork of fibrillar bundles that are connected by numerous
smaller structures that span the distance between fibres. In osteoECM substrates the coverage
with fibrillar structures is less dense compared to aaECM, but larger networks of fibre bundles
are visible. GAG structures are detectable as white sponge-like arrangements on top of the
fibrillar network [105]. The complexity of such elaborate structures deposited solely by MSC
reflects the importance of cellular processing and modification of secreted ECM proteins for the
creation of native extracellular environments. The advantage of decellularised matrices is the
preservation of the complex suprastructure of the ECM network. The hierarchical organisa-
tion of macromolecules into fibrils, microfibrils and suprastructural networks mediates specific
structural features and the overall physical properties of the extracellular environment. The
efficiency of these matrices is related to their ability to exhibit structural features of the ECM
that are responsible for the interaction of cells with extracellular signalling ligands [52]. ECM
suprastructures are composites of more than one molecular species that differ in idendity and
relative abundance. Most studies focus only on singular molecular features and mechanisms,
but it is important to keep in mind the importance of the orchestrated topography of enzymat-
ically linked and processed ECM molecules for a functional interaction between the cell and
the ECM. Studies by Cukierman [160, 161] have shown that decellularised matrices can serve
as an effective in vivo surrogate to study cellular adhesion mechanisms. Other studies have
shown that matrix proteins cause a different response of cells when they are either organised in
filaments or displayed on a flat surface [194, 195], reflecting that cells sense nanoscale surface
topographies such as spacing patterns of matrix ligands [196]. The topographical complexity of
decellularised matrices produced by BM-MSC implies that these substrates have the potential
to serve as valid in vitro model-systems for native extracellular microenvironments.
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Figure 4.2.3: Suprastructural appearance of aaECM and osteoECM substrates
Scanning eletrcon micrographs of decellularised aaECM (top panel) and osteoECM (bottom panel) substrates.
Composite fibrillar structures are arranged to suprastrucural ECM complexes. GAGs are visible as delicate white
structures attached to the fibrillar network of ECM. Scale bars as follows: left column 10μm, center column 5μm,
right column 1μm.
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Figure 4.2.4 shows the characteristics of decellularised ECM in terms of substrate height,
elasticity and total collagen, sGAG and protein content. The thickness of ECM substrates was
measured via the difference in height over a scratch in the substrate. As already implied by
SEM images (figure 4.2.3), the height of aaECM and osteoECM substrates was found to be
significantly different. The height determined for aaECM was 1.607±0.14μm (n=39) and for
osteoECM 0.883±0.08μm (n=38) (P < 0.0001). The 3-dimensional character of the substrates
can be appreciated from the line scan plot, as the substrate depicts groves and elevations
(figure 4.2.4 A left). Thereby, decellularised extracellular matrices allow some degree of 3-
dimensionality in spite of the fact that they are created in a 2-dimensional culture setup. As
important as it is for cells to be arranged in 3-dimensional patterns within a tissue, it is also
important that they can sense and interact with the elastic properties of their environment to
conduct the corresponding signalling and cell fate events [48]. The elasticity of decellularised
aaECM and osteoECM substrates was determined by AFM indentation measurements. Sub-
strate elasticity was significantly different between aaECM and osteoECM, measuring a Young’s
Modulus of 119.7±13.1Pa (n=55) and 335.0±35.17Pa (n=50), respectively (P < 0.0001) (Fig-
ure 4.2.4 B). The higher stiffness of osteoECM could results from i) the less dense, more flat
and coarse-meshed morphology of osteoECM compared to aaECM, and from ii) the process of
osteoblast differentiation of MSC including incorporation of calcium phosphate deposits into
the ECM [197]. However, both substrates describe a very soft environment, ranging at a tis-
sue stiffness comparable to that of BM [51] (see section 2.1.2). Initial studies with fibroblasts
and tumor cells have highlighted the importance of cell-ECM mechanosensing mechanisms
[198, 199]. More recent studies by Engler et al. investigating MSC differentiation, have shown
that substrate elasitcity can have profound effects on the outcome of cell fate [117]. The pro-
cess of mechanosensing, mechanotransduction and mechanoresponse is a bi-directional process
(as described in section 2.1.2). It includes integrin and ECM clustering at the cell membrane
triggering transmission of Rho GTPase and MAPKinase signalling events into the nucleus that
can alter gene expression patterns. Those changes in turn can change the presentation of ad-
hesion receptors on the cell surface and cause remodelling of ECM assemblies and cell shape
[50, 200]. Many biomaterial approaches are now trying to mimic different elasticities to in-
vestigate mechanotransduction processes and to develop new tissue engineering strategies [17].
The BM model system of decellularised matrices presented in this study can provide very soft,
gel-like substrates for the culture of human MSC and HSPC.
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Figure 4.2.4: Characteristics of ECM substrates
(A) Wet height of decellularised ECM layers. Representative height profiles of aaECM and osteoECM as meas-
ured by atomic force microscopy (AFM) over a 100μm scan length (left graph) and average data from 3 separate
MSC donors (n=30) (right graph). (B) ECM substrate elasticty measured by AFM indentation. For comparison
tissue elasticity of bone and bone marrow are depicted as dotted lines (n=4 MSC donors, min. 50 measurement
spots). (C) Total collagen (left graph) and sulphated glycosaminoglycan (sGAG) (middle graph) content of ECM
substrates (n=4 donors) compared to total protein amount of decellularised ECM (right graph, n=8) given as
μg/cm2 substrate area. All data mean ± s.e.m; asterisk denote statistical significance *P<0.05, **P<0.01,
***P<0.001.
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As mentioned in section 4.1, the BM mainly consists of collagenous and proteoglycan matrix
molecules [96, 97, 189, 190]. In vitro generated decellularised matrices were analysed for their
quantitative amount of these major ECM components (figure 4.2.4 C). Collagen was detec-
ted at a concentration of 2.399±0.361μg/cm2 in aaECM and 1.038±0.17μg/cm2 in osteoECM
substrates. This 2-fold significant difference can be attributed to the enhanced ascrobic acid
treatment and increased collagen synthesis in aaECM cultures [193]. In comparision to colla-
gen, the total protein content of decellularised matrices is also shown in figure 4.2.4 C; ranging
at approximately 3μg/cm2 for both substrates. Regardless that both, collagen and total pro-
tein values, were determined by different quantification techniques, it indicates that indeed
most of the protein that is present in decellularised matrices can be allocated to collagen.
Sulfation of GAG chains is one mechanism to add various functionalities to proteoglycans,
and almost all proteoglycans are sulfated (except hyaluronan). The assay used to quantify
proteoglycan content in decellularised matrices specifically labelled sulfated polysaccharide
components of proteoglcans or free sulfated GAG chains, such as chondroitin sulfates, keratan
sulfates, dermatan sulfates and heparan sulfates. The result shows that again aaECM contains
more proteoglycans than osteoECM per cm2 culture area (sGAG content at 1.509±0.34μg/cm2
for aaECM and 0.788±0.25μg/cm2 for osteoECM; n=4; P<0.05). The importance of collagens
and proteoglycans for stem cell function in the BM has been investigated by many studies
[104, 171, 201, 202]. The next section will discuss more closely which additional components
are present in decellularised ECM substrates.
It can be summarised that both ECM types describe representative characteristics of a BM
microenvironment in terms of their overall collagen and glycoprotein composition, as well as
depicting the appropriate elasticity and suprastructural arragenments of native extracellular
environments. To more closely decipher the molecular constituents of decellularised matrics
the next section will discuss the detailed proteomic composition of aaECM and osteoECM.
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4.3 Proteomic composition of ECM substrates
The presented MSC-generated extracellular matrices termed aaECM and osteoECM that were
introducd and described in section 4.2 were analysed for their detailed proteomic composition
to draw conclusions about the factors that are responsible for BM niche properties. Therefore,
protein extracts of ECM substrates generated by different MSC donors were separated via
SDS-PAGE and fragmented for mass spectrometric analysis. Figure 4.3.1 shows the extrac-
tion procedure to create solubilised ECM extracts. Sequential runs of differing pools of ECM
extracts are shwon in figure 4.3.1 B. For double mass spectrometric analysis (MS-MS, termed
MS2), SDS-PAGE separated samples were cut into slices for in-gel digest and MS analysis of
tryptic peptides. Figure 4.3.2 shows the cutting pattern for both aaECM and osteoECM in
parallel. The most dominant proteins from each slice of the SDS-gel are shown as a represent-
ative example for an aaECM sample. Both types of ECM displayed similar banding patterns
of fragmented proteins, suggesting reproducible proteomic configurations. Indeed, both ECM
types have a majority of proteins in common (see table 4.3.1). Unfortunately, definitive and
significant differences between aaECM and osteoECM can not yet be stipulated, since only two
separate matrix extraction runs have been analysed by mass spectrometry. However, the ECM
components that were detected in both samples are discussed in this section.
After SDS-PAGE separation of aaECM and osteoECM extracts lanes of each sample were cut
into several fragments, processed for in gel tryptic digestion and subsequently analysed via
mass spectrometry. The used orbitrap mass spectrometric analysis was highly sensitive and
detected more than thousand proteins within each sample. It is to note that many intracellular
proteins were detected in decellularised ECM extracts (for example ribosomal and cytoskeletal
proteins). However, this is related to residual intracellular protein contamination resultant
from the cell lysis procedure during decellularisation. Figure 4.3.3 shows the percentage of
extracellular matrix annotated proteins within the whole protein extract. The number of MS2
spectra are a measure for the indetification frequency of protein-specific peptides (figure 4.3.3
A). Spectrum intensity is a measure for the quantitative abundance of detected protein-specific
peptides (figure 4.3.3 B). Although, only 10% of all detected proteins are extracellular matrix
annotated the quantitative majority of ECM substrates can be related to extracellular proteins.
A full list of all identified proteins in decellularised matrices is given in appendix A.
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Figure 4.3.1: Extraction and separation of decellularised ECM substrates
(A) Extraction procedure for ECM substrates to yield soluble extracts of ECM proteins for subsequent fractiona-
tion and mass spectrometric analysis (for details see section 3.3.1). (B) SDS-PAGE gels of 3 independent protein
extraction runs. Each run describes a pool of 5 MSC donor extracts for aaECM and osteoECM, respectively.
The banding pattern shows close similarities between both ECM types and between each run.
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Figure 4.3.2: SDS-PAGE gels and cutting pattern for in-gel digestion
SDS-PAGE gel of protein extraction run 1 is shown as a representative example for the cutting pattern of in
gel-digestion before mass spectrometric analysis. A line scan for aaECM separated proteins shows the density
profile over the whole lane. Dominant proteins from each gel slice are given next to each slice and represent the
proteins from which tryptic peptides have been identified with the highest intensity.
Figure 4.3.3: Percentage of extracellular matrix annotated proteins in total sample
Percentages of extracellular matrix annotated proteins in total aaECM and osteoECM extracts are given as
(A) the cummulative number of peptide-MS2 spectra for each protein, (B) the normalised cummulative peptide
intensities for each protein and (C) the number of identified proteins. Data are mean values of run 1 and 2 of
ECM extraction.
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Table 4.3.1 lists the identified components of extracted decellularised matrices that have been
assigned as extracellular proteins by gene ontolgoy annotations for subcellular localisation.
More than 70 proteins are allocated to this group. As already discussed in section 4.2.2 the pro-
teomic analysis also revealed that the majority of ECM proteins are collagens and proteoglycan
core proteins. Many independet studies have analysed the composition of in vivo BM-ECM
[23, 96] or secreted ECM proteins of BM-stroma in vitro [102, 103]. Other studies have analysed
the transcriptome of BM-MSC and stem cell-supporting stromal cells [203, 204, 205, 206, 207].
The main proteins that frequently have been detected in almost all those studies, and which
also have been detected in this work are the following. Collagen I, collagen III, collagen V, FN,
tenascin, thrombospondin, perlecan, emilin-1, fibulin, versican, biglycan, syndecan, decorin,
osteonectin (SPARC), vitronectin, transforming growth factor-beta-induced protein ig-h3 and
connective tissue growth factor. This listing shows the amplitude of molecules that are involved
in the complex organisation of native extracellular environments. Five of the most identified
proteins in aaECM and osteoECM are going to be discussed in this section. Many proteins
that are present at very low concentrations (that were identified less often) are not neccessarily
less important for the microenvironment. The power of the compiled data has to be extrac-
ted by researching known and new relationships between ECM components and cells of the
environment.
Fibronectin was the most identified protein in decellularised ECM extracts. The amount of FN
that was secreted by BM-MSC can not be determined since FN was also used for culture setup
and anchorage of secreted ECM. Nevertheless, FN is one of the major BM-ECM components
and its ample presence in decellularised matrices partially reflects the situation of the BM
environment [208, 209]. As mentioned previously, FN interacts not only with cellular integrins
it also contains binding sites for collagens, fibrins and heparan sulfate proteoglycans [210, 211],
which also makes it an important candidate for the structural architecture of decellularised
matrices.
Another glycoprotein that has been identified in large quantities in aaECM and osteoECM
was thrombospondin-1. Thrombospondins (TSP) are caclium binding adhesive glycoproteins
that mediate cell-cell and cell-matrix interactions. TSP-1 is involved in platelet aggregation,
inflammatory response and angiogenesis [212]. It modulates angiogenesis by regulating the
activity of extracellular proteoases, such as matrix metalloprotease 9 and thereby is involved
in remodelling of ECM structures [213]. Thrombospondin contains multiple protein domains.
The amino-terminal domain has heparin-binding, cell attachment, migration and proliferation
functions, and can be recognised by syndecan, HSPG and α3β1 integrin. The type 1 domain
repeats are responsible for protein binding, TGFβ-activation and inhibition of proliferation,
angiogenesis and apoptosis. Type 1 repeats can be recognised by HSPG and β1 integrin. The
type 3 domain repeats are calcium binding and cell binding domains that are recognised by
β3 integrins [214]. These domains also contain homology sites of procollagen, FN and von
Willebrand factor [215]. TSP is cell surface associated and functions at the interface between
ECM and the cell membrane. It has the ability to form multiprotein complexes that form
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specialised regions for signalling cascades which involve activation of integrins, FAK and RAS
for cell adhesion and migration or activation of PI3K and fascin for cytoskeletal organisation
[214]. Long et al. have shown that TSP acts as a cytoadhesion molecule supporting human
HSPC in the BM [100].
Collagens are a group of structural proteins that mediate tissue strength, support and elasti-
city. They support cell growth and contain binding domains that can initiate cell signalling
[216] regulating cell adhesion and migration. Various collagens have been shown to be involved
in these mechanisms in the BM [98, 102, 217]. The collagens that were detected in this study
are collagens type I, III, IV, V, VI, XI, XII, XIV, XV, XVI. Collagen type I was the most
identified fibrillar collagen and its importance for MSC [218] and HSPC [114] proliferatin and
differentiation has been shown. For example collagen I stimulated osteogenesis of human MSC
by activation of ERK and Akt through PI3K/ERK pathway [218]. Another highly identi-
fied collagen is collagen VI, which forms microfibrillar stuctures and is assembled from three
individual α(VI) chains. Klein et al. [98] have detected collagen VI in human BM microen-
vironments and have shown that it is a strong adhesive substrate for BM mononuclear cells.
Only the triple helical domain structure could mediate adhesiveness and not purely RGD/β1
integrin interaction. These data indicate that clearly, collagens are one of the most important
ECM proteins to consider for investigation of MSC and HSPC interaction with decellularised
matrices.
Transforming growth factor-beta-induced protein ig-h3 (also termed βig-h3 or RGD-containing
collagen-associated protein) is an adhesion protein which binds to type I, II, and IV collagens
and is involved in many physiological and pathological mechanisms. The most studied patho-
logical condition involving βig-h3 is corneal dystrophy [219]. A study with recombinant βig-h3
has shown that it directly interacts with biglycan and decorin, promotes collagen VI aggreg-
ation, and participates in ternary complexing with these macromolecules [220]. The protein
contains four tandem repeats of FAS1 domains (first identified in drosophila fascilin-1) and a
carboxy-terminal RGD sequence [221]. The FAS1 domain represents an ancient cell adhesion
domain and other human proteins have been identified to contain FAS1 domains. For example
periostin which is also one of the most identified proteins in aaECM and osteoECM and which
has been shwon to be expressed by MSC [222] also contains FAS1 domains. This indicates
that FAS1-integrin interactions may play an important role for communication of BM cells
with the ECM. The cleavage of RGD-peptide from the c-terminal region of βig-h3 has been
suggested to facilitate apoptosis [223]. With its broad abundance within decelluarised matrices
and its many functions in cell adhesion and signalling βig-h3 is an intersting candiate to study
its impact on BM stem cells.
Tenascin-C is a large hexameric glycoprotein and occurs together with FN and collagen type
III in human BM [99]. Each subunit consists of EGF-like repeats, FN type III-like domains
and a fibrinogen-like terminal sequence. Interaction between BM mononuclear cells and the
mentioned binding domains has been shown by Seiffert et al. [224]. Besides its adhesive and
mitogenic properties tenascin has also been shown to be involved in migratory pathways of
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haematopoietic progenitor cells [225]. As previously shown in figure 4.2.4 C, proteoglycans are
present in large quantities in decellularied ECM substrates. A specific proteoglycan that has
been identified in large abundance within decellularised matrices was perlecan.
Perlecan (also termed basement membrane-specific heparan sulfate core protein) is a heparan
sulfate proteoglycan (HSPG) of basement membranes and pericellular matrices. It interacts
with other basement membrane components such as laminin, prolargin, collagen type IV and
extracellular matrix protein 1 [226, 227, 228], which are also detected in aaECM and osteoECM.
Perlecan is arranged in 5 distinct domains, harbouring protein motifs involved in cell growth,
adhesion and signalling [229, 230]. Many HSPG of BM are known for their ability to bind
hematopietic growth factors and present them to precursor cells in their environment [201],
whereat perlecan is also involved in collagen fibrillogenesis and structural stability of the skel-
eton [45, 231]. The abiltiy of HSPG to establish and mediate morphogen and growth factor
gradients underlines their proposed importance as building blocks for stem cell niches [232].
Many other intersting extracellular binding proteins, signalling ligands and structural proteins
have been detected in MSC-generated decellularised matrices. To investigate detailed mechan-
isms of action for spcific proteins present in decellularised matrices, the next possible steps are
targeted manipulation of cellular interaction with proteins of particular interest for BM niche
function.
Summarising, it can be said that many proteins that have been reported to be present in
BM have also been detected in MSC-secreted decellularised matrices, validating the surrogate
character of these matrices as in vitro BMmicroenvironments. It is important for future studies
to identify minimal criteria, which of the ECM components are indispensable and which are
dispensable for successful engineering of BM stem cell culture systems. Dissecting the functions
of the proteomic components will help to break down the complexity and will be of assistance to
design defined systems that mimic not only singular but also combinatorial molecular structures
of BM microenvironments.
But first, the impact of the presented complex and multifunctional decellularised culture system
is tested for its potential to interact with and support BM progenitor cells. In section 4.4 the
impact of MSC-generated decellularised matrices on MSC and HSPC culture will be discussed.
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Table 4.3.1: List of ECM proteins detected in decellularised protein extracts
Table 4.3.1 is continued overleaf.
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Proteins listed were selected via gene ontology annotations for the subcellular localisation set to extracellular
matrix. Log transformed counts of MS2 spectra of aaECM and osteoECM are given as a measure for the
identification frequency of protein-specific peptides. The represented data were drawn from run 1 and 2 of
separated protein extracts (see figure 4.3.1).
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4.4 Decellularised matrices as artificial in vitro niches
Both matrices, aaECM and osteoECM have been analysed for their morphology and charac-
teristics. To investigate their potential as artificial in vitro niches for BM stem cells BM-MSC
and G-CSF-mobilised peripheral blood HSPC have been cultured on decellularised matrices
compared to standard culture condition. The next two sections describe the observed effects
of the ECM culture model on both progenitor cell types.
4.4.1 MSC culture on ECM substrates
For MSC culture on decellularised matrices matching MSC donors were used for the prepar-
ation of ECM substrates and for subsequent re-seeding of MSC. First, MSC short-term and
long-term proliferation and expansion was investigated accompanied by cell shape analysis of
cells growing on differing culture substrates, as shown in figure 4.4.1 and 4.4.2. Control sub-
strates in use were standard plasma treated polystyrene (PTP) and covalently bound FN and
Matrigel (as described in section 3.1.2). The first striking observation when culturing MSC
on decellularised matrices is their different cell shape compared to control substrates. Figure
4.4.1 and figure 4.4.2 A shows cells in contact with ECM and control surfaces and their altered
morphology. Especially upon first contact with decellularised matrices MSC adapt a small,
elongated and fibroblast like phenotype compared to widespread and bulky cells on control
substrates. Throughout the culture period MSC on aaECM and osteoECM substrates main-
tained this phenotype and at confluence displayed a densely packed MSC layer with alinged
growth directions corresponding to the underlying fibril direction (Figure 4.4.2 A). MSC on
control substrates displayed a change in morphology towards confluence. While the cells secrete
extracellular matrix into their environment cell shape changes and adopts a more elongated
and aligned pattern. This process was observed at ealier timepoints on protein pre-coated FN
and Matrigel substrates than on plain PTP. Figure 4.4.1 shows quantitative results for different
cell morphologies, analysed at day 3 post plating. Cell area was significantly different between
decellularised matrices and control substrates FN and PTP. Cells on PTP were 4-times and
on FN 2-times bigger than on ECM substrates. Also between PTP and FN significant differ-
ences in cell area were observed. These differnces between PTP and FN were not observed
for cellular roundness. On both substrates cells displayed a spead (more round) morphology
than significantly more elongated cells on aaECM and osteoECM. Figure 4.4.2 B, shows a
representative growth curve for one MSC donor. Differences in cell shape are also reflected by
cell number at confluence. MSC on aaECM and osteoECM substrates proliferate faster and
reach confluence at an earlier timepoint than MSC in control cultures. Furthermore, due to
their smaller cell shape total cell number of expanded MSC was higher at confluence on ECM
substrates (see dotted lines in growth curve plot). In comparison, MSC on control substrates
reached confluence at later timepoints and contained less cells at the confluent state. As early
as day 6 significant differences in cell number were observed between decellularised matrices and
PTP. Although aaECM and osteoECM showed very similar results, proliferation was slightly
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increased on osteoECM compared to aaECM substrates (Figure 4.4.2 B, not significant). Long-
term expansion of MSC was investigated by serial subculture of MSC into the same substrate
condition once they have reached confluence. Figure 4.4.2 C shows 3 MSC donors and their
culture progression for up to 80 days. Different donors displayed varying proliferative capacit-
ies, reaching 7-11 passages within 60-90 days. Cummulative population doubling (CPD) was
determined and shows the same trend as observed for short term culture within one passage.
Each donor displayed best proliferation results on aaECM and osteoECM substrates. FN and
Matrigel substrates supported proliferation less effective than ECM substrates but still more
than on PTP. Especially with increasing passage number MSC on PTP lost their ability to
proliferate and went into growth arrest. On average, the cummulative population doubling for
all 3 donors was significantly 3-4-fold higher on ECM and 2-3-fold higher on FN and Matrigel
substrates compared to PTP. CPD between ECM substrates and FN or Matrigel substrates
was also significantly different. Since MSC on PTP slowly declined their proliferation rate over
the first 5 passages, relative differences in CPD did increase for the other substrates because
of their stable growth rates. Only at later timepoints relative CPD declined because growth
rates on other substrates also started to decline (Figure 4.4.2 C, average graph). Table 4.4.1
shows hypothetical absolute numbers of MSC expansion if all cells were subcultured into the
next passage at each passaging step.
The presented results for MSC culture on decellularised ECM reflect the superior character of
3-dimensional and native environments over FN coated substrates or 2-dimensional globular
protein mixtures such as Matrigel. A review by Hidalgo-Bastida et al. [233] summarised that
MSC show increased surface attachment to single protein coatings such as laminin, vitronectin,
collagen IV, collagen I and FN surfaces (in order of increasing adhesion). However, as previ-
ously mentioned, studies by Cukierman et al. have highlighted the role of 3D-matrices for
authentic matrix adhesion of cells [160]. Requirements for appropriate cell adhesion included
3-dimensionality, fibronectin and other matrix components, α5β1 integrin and pliability of the
substrate. Cell morphologies that were detected in their study on FN and 3D-matrices resemble
very much the findings in this work. This concept of force-induced and adhesion-topography-
dependent mechanosensing has also been shown by Grinnell et al. [50, 195]. Culturing fibroblast
cells in either collagen matrices or on collagen-coated coverslips induced distinct cell morpho-
logy of dendritic projections or flat spreaded cells, respectively (similar to figure 4.4.2 D).
Mechanotransduction and the resulting cellular deformation activates downstream signalling
events, for example MAP-kinase pathway, which has been shown to enhance MSC proliferation
[234]. Another study has shown that proliferation and cell cycle of various cells is controlled in
a conserved way by matrix elasticity [235] via adhesion mediated mitogenic events. Lindner et
al. have shown that culture of MSC on Matrigel coated surfaces resulted in improved prolifer-
ation and differentiation [236]. However, as shown by this work, decellularised matrices have
been able to augment the proliferative potential of BM-MSC to a greater extent than Matrigel
substrates. Conventional in vitro expansion of MSC implies extended cell culture on PTP
substrates. Baxter et al. have shown that this results in rapid cell aging and growth arrest
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involving telomere shortening [180]. The presented culture system of decellularised matrices
has been able to delay this aging process, while supporting appropriate cell morpholgy and
long-term proliferation.
Figure 4.4.1: Cell shape of MSC cultured on decellularised matrices
Cell shape analysis of MSC grown on ECM and control substrates. The cellular cytoskeleton is labelled with
phalloidin at day 3 post plating. Cell area (μm2) and cell roundness (1 describes a perfect circle) were analysed
graphically (n=min. 50 cells). SEM images show MSC in close contact with the ECM fibres and with GAG
structures (white structures). Black arrows piont out cells that are intermerged within the 3D-matrix. Scale
bar on fluorescene images at 100μm, and on SEM images at 50μm. All data mean ± s.e.m; asterisk denote
statistical significance ***P<0.001.
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Figure 4.4.2: MSC culture on decellularised ECM substrates
Figure 4.4.2 is continued overleaf.
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(A) MSC of passage 2 cultured on control substrates PTP, Matrigel and FN and on aaECM and osteoECM at
the onset of culture 3 days post plating (left column) and at confluence (right column). Scale bars at 100μm.
(B) Short-term culture of MSC over the period of one passage (p2), representative for one MSC donor. MSC
grown on ECM substrates reach confluence at an earlier timepoint and reach higher cell numbers than control
cultures (dottet lines). As early as day 6 significant differences in total cell number/cm2 were observed (n=3
donors). (C) Long-term culture of MSC over 7-10 passages, as shown by 3 independent MSC donor experiments,
as cummulative population doubling (CPD) over time. Cells were subcultured at confluence to the same plating
densitiy. Average CPD relative to PTP substrate was analysed for all 3 donors at 10 day intervals. Significance
is given relative to PTP. All data mean ± s.e.m; asterisk denote statistical significance **P<0.01, ***P<0.001.
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Table 4.4.1: Expansion of MSC
PTP Matrigel Fibronectin osteoECM aaECM
Donor 1
final passage p7 p9 p9 p10 p10
total cell number 0.008 x 108 0.2 x 108 0.3 x 108 10 x 108 49 x 108
Donor 2
final passage p6 p8 p8 p9 p9
total cell number 0.001 x 108 0.2 x 108 0.04 x 108 2.2 x 108 1 x 108
Donor 3
final passage p9 p10 p10 p11 p11
total cell number 0.8 x 108 22 x 108 41 x 108 55676 x 108 2319 x 108
Each donor was cultured for the same duration of time on the given substrates. The starting cell number at
the beginning of culture (p2) was 54.000 cells for all donors on all substrates. Cells were only subcultured at
confluence and the final passage states the maximum of passages that were reached within the given time. Total
cell number describes the possible yield of expanded cells calculated from the cummulative population doubling
over the given time period. (See also figure 4.4.2 C)
One criterium of MSC is their ability to differentiate along the various meschencyhmal lineages.
To study the potential of decellularised matrices to support MSC differentiation, MSC of pas-
sage 2 were induced to differentiate into osteoblasts and adipocytes while cultured on ECM
and control substrates for 2 weeks. Figure 4.4.3 shows quantification of differntiation intensity.
Osteogenic differentiation was determined by van Kossa staining for mineral deposition (Fig-
ure 4.4.3 A). Adipogenic differentiation was determined via Oil Red O staining for fat droplet
accumulation (Figure 4.4.3 B). After the given differentiation time significant differences in dif-
ferentiation intensity were observed for both osteogenic and adipogenic differentiation between
cultures on decellularised ECM and control substrates. Osteogenic induction of MSC caused
intense mineralisation in aaECM and osteoECM substrates. Both significantly higher than
all control substrates. But aaECM also showed significantly higher mineralisation values than
osteoECM. In all cultures no mineralisation was observed when cultured with control medium
containing no osteogenic inducers. This indicates that ECM enviroments alone (for example os-
teoECM matrices) do not induce osteogenic differentiation. Also for adipogenic differentiation
decelluarised matrices have shown very similar results. ECM substrates have shown enhanced
numbers of adipocytes with intense fat droplet accumulation compared to control substrates.
A significant difference in adipogenic differentiation was also observed between aaECM and
osteoECM. This shows that osteoECM is less supportive for adipogenic differentiation, which
might be correlated to the osteogenic environment of osteoECM. Cultures without adipogenic
induction did not show any adipocytes or fat droplet accumulations. Within control substrates
(between PTP and FN or Matrigel) no difference in differentiation behaviour was observed,
which validates the importance of native ECM environments for differentiation processes.
MSC are also a source of many secreted factors which stimulate and regulate the behaviour
of cells in their environment or of themselves. Therefore, the secretory profile of MSC un-
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der different culture conditions was investigated. MSC of passage 2 were cultured for 3 days
on decelularised ECM and PTP substrates and conditioned medium was collected for detec-
tion of secreted cytokines. By the use of a cytokine dot blot array pooled and normalised
supernatants of 3 MSC donors were analysed (see figure 4.4.4 A). Pixel intensity of positive
dots was determined and is a measure for the cytokine level in MSC culture supernatants.
Interleukin-6 (IL-6), Interleukin-8 (IL-8) , and serpin E1 were detected with high intensity.
Interleukin-13 (IL-13) and stromal cell-derived factor 1 (SDF-1) were detected at lower intens-
ities. Unfortunately, background levels for serum contanmination by the cell culture medium
could not be subtracted. Therefore, more precice quantitative measurements were performed
via ELISA for IL-8 and other known MSC-secreted cytokines that play important roles in the
niche, namely angiopoietin-1 (Ang-1) and SDF-1. Figure 4.4.4 B shows detected amounts of
cytokine as pg/10.000 cells, whereat serum background levels have been subtracted. IL-8 secre-
tion was significantly different between PTP and ECM substrates on day 1, and secretion levels
dropped down in all culture conditions the following days. Ang-1 has shown elevated secretion
levels for all 3 days by MSC cultured on osteoECM substrates compared to PTP. During the
first 2 days of culture also a significant differences to aaECM Ang-1 levels have been detected.
SDF-1 secretion by MSC steadily increased over the 3 day culture period. On day 1 and 3
MSC cultured on aaECM showed significantly higher SDF-1 secretion levels than cells on PTP
and osteoECM. The amount of cytokine that has been detected in supernatants that were only
in contact with plain ECM substrates was very low, indicating that the decellularisd ECM
substrates do not contain or do not release large amounts of cytokine.
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Figure 4.4.3: MSC differentiation on ECM and control substrates
Figure 4.4.3 is continued overleaf.
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Osteogenic (A) and adipogenic (B) differentiation of MSC on ECM and control substrates visualised by vanKossa
staining for mineral depostion and by Oil Red O staining of cellular fat droplet accumulation, respectively.
Differentiation (induced) and control (standard MSC medium) treatment are visualised microscopically (left
panel) and macroscopically by plate view (right panel), representative for one MSC donor. Insets in ECM
control images depict staining of plain ECM substrates. Quantification of differentiation intensity represents
data from 3 independet experiments with 3 different MSC donors. Scale bars at 100μm; all data mean ± s.e.m;
asterisk denote statistical significance *P<0.05, ***P<0.001.
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Figure 4.4.4: MSC cytokine secretion
Secreted cytokine levels in conditioned media of MSC in contact with PTP, osteoECM and aaECM, analysed
at day 1,2 and 3 post intial contact with the substrate. (A) Detected cytokines on a dot blot membrane from
MSC cell culture supernatants pooled from 3 different MSC donors (normalised to 10.000 cells). Cytokine levels
were analysed as pixel intensity of duplicate dots. (B) Quantitative analysis of IL-8 (left graph), Ang-1 (middle
graph) and SDF-1 (right graph) cytokine levels from separate supernatants (n=3 dnors) given as pg/10.000 cells.
All data mean ± s.e.m, asterisk denote statistical significance *P<0.05, **P<0.01, ***P<0.001.
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Previous data by Seib et al. [237] have shown that artificial constructs of individual ECM
proteins (tropocollagen, fibrillar collagen, collagen/hyaluronic acid and collagen/heparin) had
rather limited effects on the cellular behaviour of BM stem cells in comparison to standard
PTP substrates. For example the secretion level of Ang-1 and SDF-1 was not affected by the
culture substrates and even less than on PTP substrates. The detected cytokines secreted
by BM-MSC were also identified by another study, such as IL-6, IL-13 and SDF-1 [70]. Seib
et al. also showed that the secretory profile of MSC is dependent on matrix elasticity [238].
Although much stiffer substrates were used in that study similar cytokine secretion was detected
in comparison to this work. Due to their elevated secretion levels of pro-angiogenic factors such
as IL-8, SDF-1 and Ang-1 [239], MSC expanded on decellularised substrates are a viable cell
source for use in tissue engineering and cell therapy approaches.
Differentiation of MSC on decellularised matrices has shown drastic increase in mineralisation
of osteogenic induced cultures. The potential of ECM substrates to aid ostegenic mineralisa-
tion is intrinsic to its character as nucleation network for calcium phosphate deposition [197].
For example, identified components of decellularised ECM such as thrombospondin [240] and
periostin [222] are know for their role in extracellular matrix mineralisation. Other studies have
investigated the pre-coating of tissue engineering scaffolds with rat osteoblast-generated matrix
layers and found that culture of MSC on such scaffolds dramatically increased their bone form-
ation capacity [21, 22]. This indicates that decellularised matrices are useful for application
in various biomaterials concepts to guide differentiation of MSC into the osteogenic phenotype
and aid mineralised bone formation. In a recent review by Engler and Reilly [241] intrinsic
ECM properties such as structural, biochemical and mechanical cues were directly linked to
cellular phenotype of MSC. MSC differentiation is regulated by integrin mediated adhesion
to tissue specific ECM molecules. Additionally to the right set of adhesion sites, ECM topo-
graphy and elasticity also causes changes in cell shape associated with force generation within
the cell which activates differentiation signalling cascades and alters gene expression [241]. De-
cellularised matrices exhibit those mentioned regulators more appropriate and demonstrated
more effective MSC differentiation and proliferation than control substrates, which lack critical
parameters of this multifunctionality. MSC are furthermore conditioned by their extracellular
environment and pre-destined to follow certain lineage pathways once they have adapted to
signals of their environment. Irreversible epigentic changes prime the cell to respond in par-
ticular ways to further stimuli [242] which diminishes their multipotentiality. Here may lies
one of the reasons why MSC expansion or differentiation on PTP, FN or Matrigel substrates
displayed impaired culture outcome. This indicates the importance of the culture environment
for maintenance of a functional cellular phenotypes for subsequent use in specific cellular assays
or applications that require cellular plasticity.
Very recent studies by Chen and colleagues have used a very similar approach of cell-free ECM
substrates for MSC culture [243]. They could show that culture of murine [244] or human
[245] BM-MSC on decellularised MSC matrices also supported rapid expansion of cell num-
bers and improved differentiation into adipocytes and osteoblasts compared to PTP cultures.
78
CHAPTER 4. RESULTS AND DISCUSSION
Transplantation of ECM expanded murine cells generated 5-times more bone and 8-times more
hematopoietic marrow compared with cells expanded on plastic. Furthermore, they have shown
similar results for transplantation of human MSC expanded on cell-free ECM substrates. After
expansion for multiple passages cells retained their capacity for skeletogenesis compared to dra-
matically diminished bone formation capacity of cells expanded on PTP. In conjunction with
these studies, Sun et al. [246] found that decellularised matrices generated by young murine
femoral cells (3 months old mice) were able to restore defects in self-renewal and bone forma-
tion capacity of old MSC (from 18 months old mice). ECM substrates prepared from old MSC
were not able to support MSC self-renewal and osteogenesis. These findings are in line with
the results from this study and approve the functionality of long-term expanded MSC. Analysis
of global gene expression patterns of human MSC cultured on ECM substrates compared to
PTP revealed that most of the genes that were differentially up-regulated on ECM substrates
were genes involved in cell cycle processes, mitosis, cytoskeleton and cytoskeleton-dependent
intracellular transport [245]. Another gene expression study by Song et al. identified decorin
and thrombospondin-1 as one of the genes involved in MSC self-renewal and multipotency [87].
Together with the data obtained by mass spectrometry of decellularised matrices the mechan-
isms of MSC self-renewal can be elucidated by analysing specific interactions between ECM
and MSC.
Taken together, BM-MSC have shown to react to a great extend to decelluarised ECM sub-
strates compared to standard culture conditions on either protein coated FN and Matrigel or
PTP substrates. The pre-deposited proteins, fibrils and GAGs served as guiding structures for
growth and migration of MSCs. Both types of decellularised matrices, aaECM and osteoECM,
were able to significantly improve cytokine secretion, proliferation and differentiation capacity
of primary MSCs ex vivo.
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4.4.2 HSPC culture on ECM substrates
The complex interaction between MSC and HSPC within the BM regulates stemness of both
stem cell types. Previous MSC-HSPC co-culture studies have revealed the potential of such
culture systems in terms of HSPC self-renewal and expansion [70, 93, 247, 248]. This study
applied a minimal co-culture system, using only the extracellular residues of MSC as a culture
environment for HSPC. Peripheral blood CD34-isolated human progenitor cells were cultured
for a period of one week in contact with aaECM, osteoECM, FN and PTP substrates to in-
venstigate the potential of MSC-made ECM to support and expand HSPC. Figure 4.4.5 shows
progenitor cells cultured on PTP and decellularised matrices. Cells appeared in close interac-
tion with the underlying ECM substrates, indicating an adhesive inter-communication between
the matrix substrate and progenitor cells. Cells were analysed via flow cytometry for cell sur-
face marker expression, as shown in figure 4.4.6 C. It was found that CD34+ HSPC were able
to proliferate and expand on ECM substrates. Total expansion of the HSPC population was
significantly higher when in contact with aaECM and osteoECM environments, compared to
PTP and FN substrates (Figure 4.4.6 A). Table 4.4.1 shows absolute values for expansion of
CD34+ and CD34/CD133 double positive cells. Allowing an up to 3-fold expansion of CD34+
cells, aaECM was the most potent substrate in supporting HSPC maintenance and expansion.
OsteoECM allowed a duplication of CD34+ cells in relation to the starting cell number. PTP
substrates maintained the initial population size, whereat on FN substrates cell numbers de-
clined. Although, on control substrates cell numbers were only steady or declined, the amount
of dead cells in the final population was not significantly different between all culture sub-
strates; analysed by propidium iodide live/dead staining (PTP 2.92±0.6% and FN 2.85±0.6%
compared to osteoECM 1.7±0.3% and aaECM 1.62±0.3%). Also the percentage of CD34,
CD133 and CD177 expressing cells was not significantly different between cell populations from
all different substrates (Figure 4.4.6 B). Only between PTP and aaECM a significant difference
was observed for the percentage of CD34+ cells in the total population. This is most likely
related to the enhanced expansion of progenitor cells (and subsequent appearance of CD34-
differentiated progenitors) in aaECM cultures, compared to the non-proliferating cell popula-
tion in PTP cultures. The described experiments were performed with cytokine-washed ECM
substrates (see section 3.1.3 for preparatory details). It was tested if decellularised matrices
contained active amounts of residual signalling molecules such as growth factors and cytokines.
Figure 4.4.7 shows expansion of HSPC on native and cytokine-washed decellularised matrices.
Both conditions yielded the same expansion of progenitors, indicating that none or ineffective
amounts of cytokines remained within the ECM. The amount of soluble factors released by the
washing procedure was below the detection limit of ELISA quantifications for IL-8, SDF-1 and
Ang-1 (data not shown), as previously described to be secreted by MSC (see figure 4.4.4). This
indicates that decellularised matrices (native or cytokine-washed) are mostly free of remaining
cytokiens, but it is thought that they have the potential to bind and present cytokines (for ex-
ample present in culture medium, or individually applied) via proteoglycans and glycoproteins
in a more efficient way than plain PTP substrates (discussed further down in this section).
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Figure 4.4.5: HSPC cultured on ECM and PTP substrates
Culture of peripheral blood G-CSF-mobilised CD34+ HSPC on decellularised aaECM and osteoECM substrates
and on control PTP substrate at day 7. Phase contrast images (upper three) show all cells in suspension on
PTP surfaces. Note the close interaction of HSPC with the decellularised ECM layer and the flat morphology of
adherent HSPC (arrow heads). SEM micrographs (lower panel) show interaction of HSPC with the surrounding
ECM and especially with GAG structures, pictured as white structures around the cell. Scale bars at 100μm on
phase contrast, and at 5μm on SEM images.
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Figure 4.4.6: Culture of HSPC on ECM substrates
(A) Overall expansion of HSPC cultured for 1 week in low cytokine conditions (10ng/ml SCF, Tpo, Flt-3)
on cytokine-washed decellularised matrices, PTP and FN substrates. Expansion of CD45+ and CD34+ (but
not CD34/CD133+) cells was significantly higher on matrix substrates compared to PTP. (B) Percentage of
progenitor cells in the total cell population. Expression of surface markers was not significantly different between
substrate conditions, except CD34 expression between aaECM and PTP. (C) Example of flow cytometric analysis
for CD45, CD34, CD133 and CD117. Tinted plots represent unspecific isotype control antibodies conjugated to
the respective fluorophor. Almost no difference in expression intensity of surface markers between cells from
different substrates was observed. All data mean ± s.e.m, asterisk denote statistical significance *P<0.05,
**P<0.01, ***P<0.001.
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Table 4.4.2: Expansion of HSPC on ECM substrates
PTP Fibronectin osteoECM aaECM
final cell number CD34+ cells 6.7 ± 1.3 x 104 3.0 ± 0.8 x 104 11.7 ± 2.5 x 104 14.9 ± 2.3 x 104
fold expansion CD34+ cells 1.2 ± 0.2 0.5 ± 0.1 2.1 ± 0.4 2.8 ± 0.3
fold expansion CD34/CD133+ cells 0.5 ± 0.1 0.2 ± 0.1 0.8 ± 0.2 0.9 ± 0.2
The starting cell number for all HSPC culture experiments was set to 5-6 x 104 cells/9cm2 culture area. Total
expansion of CD34+ cells over the time course of one week is given in row one. Rows two and three quote the
fold-expansion of CD34+ and CD34/133 double positive cells. Data for PTP, osteoECM and aaECM n=6; for
FN n=3.
Figure 4.4.7: Comparison of cytokine-washed and native ECM
Expansion of CD34+ HSPC cultured for 1 week in low cytokine conditions (10ng/ml SCF, Tpo, Flt-3) on native
and cytokine-washed decellularised matrices, PTP and FN substrates. Expansion of CD45+ and CD34+ (but not
CD34/CD133+) cells was significantly higher on matrix substrates compared to PTP. No significant difference
between native and cytokine-washed ECM substrates was detected in terms of HSPC expansion.
The application of cytokines for ex vivo expansion of HSPC has been investigated by many
studies. For instance, early cultures of human BM-, peripheral blood- and cord blood-derived
stem cells with various cytokine combinations (mainly SCF, Flt-3, IL-6, IL-3 and Tpo) resulted
in 2- to 5-fold expansion of long-term repopulating cells after 4 to 21 days in culture [249,
250, 251, 252, 253]. But as the field of HSCP culture advanced, more sophisticated culture
systems emerged. Physcial immobilisation of the extracellular domain of the Notch ligand
Delta1 in combination with FN fragments and soluble cytokines for the culture of human
cord blood HSPC led to a nearly 16-fold increase in NOD/SCID repopulating cell frequency
[254, 255, 256]. In this study hematopoietic progenitor cells were cultured at very low cytokine
concentrations, and the repopulation ability of the expanded progenitor cells still remains to
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be analysed in ongoing experiments. But, using decellularised matrices in conjunction with
elevated concentrations and refined mixtures of cytokines might enhance the effect of stem cell
expansion.
Several previous studies have examined the role of single ECM molecules and their interaction
with cell surface receptors for haematopoietic stem cell maintenance. Adhesion receptors of
HSPC sense and regulate the interaction between the cell and the extracellular environment
[257]. For example, HSPC culture on planar FN substrates initiated direct adhesion of progen-
itor cells via α4-integrin receptors to the heparin binding domain of FN and inhibited HSPC
proliferation [258], similar to the finding in this study (see figure 4.4.6 A). ECM molecules like
fibronectin [259], laminin [260], fibrillar collagen I [114] and heparan sulfate GAGs [201] have
been shown to support primitive HSPC maintenance in vitro. On the other hand, inhibition
of collagen deposition by stroma cultures prevented haematopoiesis in long-term BM cultures
[217], fostering the importance of secreted extracellular structures. One important aspect of
decellularised matrices is that ECM components, and especially GAG components, can bind
and present cytokines and signalling molecules in a biologically active manner. Studies with
BM stromal cell heparan sulphates demonstrated the importance of GAG-mediated cytokine
presentation for HSPC maintenance [104, 231, 232]. Potentially, the cytokine cocktail used
in this study was presented in a more funtional way, or was preserved for longer periods on
decellularised matrices than on PTP or FN substrates. However, the SCF receptor CD117 was
not differentially expressed on progenitor cells in contact with extracellular matrices compared
to control substrates (Figure 4.4.6 D). This might be related to the finding that membrane
bound SCF is more effective in active and prolonged signalling into HSPC [261]. The applica-
tion of higher amounts of SCF or in depth analysis of subsequent signalling events after CD117
activation might reveal differences in SCF interaction with HSPC on ECM or PTP substrates.
In this study, HSPC were exposed to an orchestrated mixture of ECM factors and extracellular
signalling molecules. Many components that were detected via mass spectrometric analysis
of decellularised matrices (see table 4.3.1) have been shown to play important roles in HSPC
regulation. A few examples are discussed to show the versatile influence of ECM components
on HSPC. Tenascin is a large glycoprotein which plays an important role as a cytoadhesive
component within the haematopoietic microenvironment. Klein et al., have shown that stromal
cells strongly express tenascin and that it is co-distributed with fibronectin and collagen type
III around maturing haematopoietic cells in the BM [99]. The glycoprotein thrombospondin
showed similar effects, influencing cell-cell and cell-matrix adhesion of haematopoietic progen-
itor cells [100]. Fibulins are glycoproteins that can associate with elastic fibres such as elastin
and fibrillin [262]. Gu et al. reported that fibulin-1 and fibulin-2 associate with fibronectin
in BM stroma and adhere to haematopoietic cells via β3 integrins [211]. The dual impact of
fibronectin and laminin on murine BM cells was examined by Sagar et al., and was shown to
enhance expansion of primitive stem cells and improve BM engraftment in mice [260]. One
example of a secreted signalling molecule detected in decellularised ECM extracts is Wnt-5b.
Wnt (Wingless) signalling has been shown to limit proliferation and preserve the stem cell
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character of HSPC within the niche [263, 264, 265]. Collectively, all these molecules influence
haematopoietic progenitor cells via activation of cell surface receptors and cause subsequent ini-
tiation of signalling cascades. Furthermore, the collective behaviour of extracellular matrices
also describes a physical microenvironment that exerst stimuli towards the responding cell
type. As mentioned previusly for MSC, also HSPC are influenced by the elasticity of the
substrate. Holst et al. [266] were able to show a 3-fold tropoelastin-dependet expansion of hu-
man CD34+/CD38- HSPC. The effect was related to the extensional elasticity of tropoelastin,
indicating that HSPC can sense and react to physical properties of their environment. The
importance of 3-dimensionality was shown by Kurth et al., where spatial costrains of progenitor
cells in FN-coated microcavities caused cellular quiescence [126]. Along that line, differences in
expansion intensity between aaECM and osteoECM substrates might arise from the difference
in physical properties of both substrates (see figure 4.2.4). aaECM exhibited a thicker (more
3-dimensional) and more elastic phenotype than osteoECM. But the detailed mechanisms of
action still need to be investigated to draw conclusions about the functionality of both ECM
types. Further indications for differential regulation of HSPC via aaECM and osteoECM sub-
strates can be expected from the statistical analysis of the proteomic composition of ECM
extracts, which is ongoing.
Hines et al. tried to summarise the complex nature of haematopoietic stem cell niches including
cell adhesion molecues, growth factors, cytokines and chemokines [267]. Many components of
the extracellular space that are listed as crucial factors for a functional niche have also been
detected in this study. For example, glypican, collagens, decorin, FN, hyaluronic acid, laminins,
nidogens, tenascin, thrombospondin and vitronectin were all found in aaECM and osteoECM
extracts. The function of additionally detetected components, as either important factors for
the assembly of extracellular structures or as adhesion sites for stem cell signalling has to be
investigated. The obvious complexity of the decellularised ECM system exerts its supportive
effect on HSPC most likely through multiple gateways. This system permits investigation of
activated or inhibited signalling pathways, which direct HSPC into the observed phenotype.
To proof the functionality of ECM-expanded HSPC, repupulation and BM engraftment studies
are on the way at present. These experiments will show the true potential of decellularised
matrices in expanding primitive haematopoietic progenitor cells with the ability to home to
the BM and produce mature haematopoietic cells. Identificaion of adhesion receptors and gene
expression profiles will help to gain more insight into mechanosensing, proliferation, cell-cycle
and self-renewal signalling events of HSPC. Thereby, this system of decellularised ECM will be
invaluable for the establishment of tissue-specific culture environments that facilitate control
of cell fate for therapeutic applications.
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Chapter 5
General Discussion
5.1 Summary and conclusions
Among the factors that regulate cellular phenotype and cell behaviour the extracellular matrix
is inarguable one of the most important. All cells within the body are surrounded by organ and
tissue-specific extracellular material that bears superordinate functionalities, such as regulation
of cell shape, migration, gene expression and subsequent maintenance or changes in cellular
response. Over the past decade more light has been shed on the impact of ECM properties such
as suprastructure, molecular interaction between ECM components, physicochemical signals
and mechanisms of mechanotransduction. In the field of stem cell biology the concept of
specific extracellular microenvironments, so called ’niches’, which control self-renewal and cell
fate arose. Along that line, this thesis was set out to mimic the multifunctional character of
cellular microenvironments to establish a culture systems that supports adult stem cells in
vitro.
In the frame of this work a novel and highly complex surrogate culture model has been de-
veloped to mimic the in vivo ECM environment of human bone marrow. Primary human bone
marrow stromal cells were successfully utilised for secretion of extracellular matrix components
in a native and functional manner. The presented in vitro culture system can exhibit diverse
characteristics and implies versatile options for its use as a stem cell niche model. Bone mar-
row stem and progenitor cells - MSC and HSPC - have been successfully stimulated by the
surrogate culture substrate for expansion and differentiation, involving complex interactions
with decellularised extracellular matrices.
Decellularisation of tissues and cell cultures is a practicable strategy to investigate the impact
of the ECM and study cellular behaviour upon contact with extracellular molecules. How-
ever, unlike decellularised organs decellularised cell cultures have not extensively been used as
model systems for the study of authentic and methodical cell-ECM interactions [19]. One of
the reasons for this discrepancy, and one major drawback of these systems is the difficulty of
yielding intact and homogeneous extracellular matrix structures following the decellularisation
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procedure. A critical accomplishment in the beginning of this work was the reliable and secure
anchorage of cell-secreted matrix components to the culture carrier. Adsorptive binding of
secreted ECM to hydrophobic plasma treated surfaces alone is not sufficient, and a common
drawback during fabrication of decellularised matrices is delamination of freshly formed ECM
sheets from the culture carrier. This results in unsatisfactory recovery rates of homogenous
and suitable matrix substrates for cell culture applications. Therefore, a novel approach was
developed that facilitates covalent binding of coupling agents to preserve the link between ECM
and substrate. The newly established method involved integrated covalent attachment of (1)
aminosilane, (2) poly(octadecene alt maleic anhydride) thin films and (3) human fibronectin
and thereby allowed incorporation and anchorage of cell-secreted ECM into the coupling layer,
as shown in figure 5.1.1. Fibronectin was an ideal binding platform for cell-secreted extracel-
lular molecules as it has the ability to interact with collagen, heparin and fibrin via internal
binding domains (fibronectin type I, II and III domains). Also the hydrophobic character of
poly(octadecene alt maleic anhydride) and its long alkyl chains mediated hydrophobic interac-
tions between secreted matrix molecules and the substrate surface. Beneficial effects were not
only appreciable during ECM deposition, but especially throughout the processing of decellu-
larised matrix layers and their subsequent use in culture experiments. Thus, this novel binding
system permits long-term cross-linkage of segregated ECM networks and is invaluable for the
reliable establishment of decellularised extracellular matrices.
It was the aim of this study to develop in vitro cell culture systems that mimic extracellular
matrix structures found in the natural human bone marrow microenvironment. Pioneering
work by Cukierman et al. has demonstrated the effect of fibroblast-generated decellularised
matrices on in vivo-like cellular adhesion mechanisms and cell morphology. However, tissue
specific decellularised matrices for the bone marrow have not been extensively described. There-
fore, mesenchymal stromal cells were chosen for the creation of extracellular matrix substrates
as they are known for their properties as matrix secreting cells and major regulators of bone
marrow stem cell niches [24, 93]. Early passage human MSC were cultured on FN-coated ad-
hesive surfaces and were allowed to secrete ECM components. Within 10 days human primary
BM-MSC have produced dense and homogenious sheets of extracellular matrix material. The
presented coupling strategy resulted in stable and processable MSC-derived matrices (from now
on termed MDM ). Furthermore, the outcome of fabricated matrices was tuneable by means of
differential MSC-stimulation over the period of matrix secretion. Two types of MSC-secreted
matrices have been developed according to specific characteristics of the bone marrow. Colla-
gen is the most abundant ECM protein in bone marrow and in the whole body and is important
for tissue integrity and stability. In dependence of ascorbic acid MSC have shown elevated se-
gregation of collagen into their environment. Matrices that were generated under ascorbic acid
stimulation were termed aaECM and yielded collagen rich extracellular matrices. Osteoblasts
are progeny of MSC with supposed regulatory functions towards haematopoietic progenitor
cells within the osteogenic stem cell niche of trabecular bone [92]. Stimulated osteoblast differ-
entiation of MSC during their ECM secretion phase resulted in otseogenic extracellular matrices
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that were termed osteoECM. Although different primary MSC donor populations were used
for repeated matrix segregation, the individual and characteristic appearance of both matrix
types was largely consistent. Taken together, the first aim of this thesis was accomplished by
the establishment of a method that allows stable, variable and reproducible construction of
surrogate bone marrow ECM in vitro.
Figure 5.1.1: Stabilisation of MSC-secreted ECM
Schematic representation of the coupling strategy for improved anchorage of MSC-secreted ECM to the
substrate surface.
Based on this first accomplishment, the next goal was to characterise such in vitro microen-
vironments. The surrogate nature of decellularised aaECM and osteoECM substrates was
substantiated by analysis of their compositional, topographical and elastic properties. Molecu-
lar and physicochemical cues direct cellular morphology, migration, proliferation and survival.
Therefore, it is crucial that MDM have the ability to mimic these properties in a functional
and native manner.
Many studies have been able to demonstrate the importance of single or multi-component
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matrix preparations on cellular behaviour [232, 268, 269]. But, these approaches involve limit-
ations as they cannot address the complex interaction of manifold ECM molecules towards the
cell [237]. Microarray analysis have tried to decipher which genes are activated in early MSC,
including secreted extracellular matrix components [203, 205]. However, a detailed proteomic
identification of extracellular molecules secreted by MSC has not been done so far. In this
study the complex composition of decellularised extracellular matrices was revealed by highly
sensitive mass spectrometric analysis of complete protein extracts. Unlike identification of only
a hand full of proteins via proteomic studies involving 2-dimensional electrophoresis techniques,
here more than 70 proteins with gene ontology annotations for extracellular matrix classific-
ation have been identified. Many of the identified proteins can be allocated to the family of
either collagens or proteoglycans. This implies that among many others, functionalities such
as structural guidance and growth factor presentation are crucial to the microenvironment.
In dependence of varying stimuli both MDM types demonstrated differing abundance of these
major ECM components, validating their distinct characteristics. aaECM reflected a higher
abundance for collagens and sulfated glycosaminoglycans than osteoECM, which arised from
the elevated ascorbic acid treatment. However, in consideration of their overall proteomic com-
position, both ECM types demonstrate very similar results. This indicates that MSC secrete
a consistent set of fundamental BM-specific ECM components and upon external stimulation
or differentiation into osteoblasts their quantitative abundance is changed. Definitive differ-
ences between aaECM and osteoECM in absolute abundance of selective proteins have to be
elucidated by further statistical analysis of mass spectrometric data (3rd repetition currently
on the way). Thereby, differences in aaECM and osteoECM properties can be addressed more
specifically. In general, the appearance of MDM is highly complex in its composition. Many of
the identified proteins are involved in the assembly of micro- and supra-structural elements of
extracellular matrices. For example proteins like fibulin aid formation of fibronectin-containing
matrix fibres. Others are involved in enzymatic post-tanslational processing of extracellular
molecules, such as hydroxylation of collagen or deamination of collagen or elastin. Metallo-
proteinases and their inhibitors are important regulators of ECM remodelling and were also
detected in decellularised matrices. In the same way, but though very rare, soluble signalling
ligands like the Wnt-protein 5b were also detected at low frequencies and demonstrate that
functional components such as growth factors and cytokines are present too. In conjunction,
the entity of proteins in the system comprises all necessary parameters for cell adhesion, cell mi-
gration and activation of cell signalling events. The most frequently identified components such
as collagens, fibronectin, thrombospondin, tenascin and others have been categorised as major
constituents of the natural bone marrow extracellular environment [23, 96]. This demonstrates
that the secretory behaviour of primary MSC in vitro has been very similar to their natural
behaviour in vivo, and argues for the close resemblance of the established MDM substrates
with native extracellular BM conditions.
The varying stimuli used for the creation of different ECM types also resulted in varying to-
pography and elasticity of MDMs. As it can be derived from the compositional complexity of
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matrix extracts, the cell-free extracellular matrices harbour capabilities to reflect supramolecu-
lar structures of native ECM assemblies. Cell-made matrices have the advantage that processes
like post-translational modification, active fibrillogenesis, aligned deposition and remodelling
of matrix molecules is conducted in a physiological manner. The established MDM substrates
comprise complex suprastructural elements of natural matrix assemblies. Large fibres are as-
sociated with smaller fibrils and tethered glycosaminoglycans were layered down in an oriented
fashion according to the cellular orientation. After decellularisation the structural aspect of
the ECM remained and contained some degree of 3-dimensionality. Osteogenic type ECM
demonstrated large and coarse-meshed fibre structures but resembled a rather flat morphology.
In contrast, aaECM revealed dense fibre-networks with numerous fibrillar interconnections and
a thickness of about 2μm, including topography changes at a sub-cellular range. The morpho-
logy of the fibre network, fibre cross-linking and non-covalent interactions with other matrix
proteins also contributes to matrix elasticity. Bone marrow is a highly viscous tissue ranging
at a very small elasticity of 0.1kPa. Here, the Young’s Modulus of decellularised substrates
demonstrated a similar and very soft character, ranging at 0.1 and 0.3kPa, for aaECM and
osteoECM respectively. The soft elasticity of matrices secreted by MSC undergoing osteoblast
differentiation might be due to the short differentiation time and limited mineral deposition.
The given characterisation of MDM implies that these cell-made ECM systems have the ability
to mimic and display most functional aspects of in vivo ECM systems, such as presentation of
adhesion sites within ECM molecules, mechanical stability and elastic extensibility and present-
ation of growth factors and soluble ligands by glycoproteins and proteoglycans. In comparison
to other bioengineered culture systems, which systematically present only single aspects of the
microenvironment, this system allows to probe all these multiple parameters at the same time
for their potential to synergistically support BM stem cell expansion in vitro. In conclusion, the
second goal of this work has been accomplished by identifying the molecular composition, the
topographical architecture and the elastic properties of MDM. The presented ECM substrates
resemble the physicochemical properties of complex bone marrow microenvironments.
The next goal was to support and expand BM stem cells ex vivo by the help of the developed
surrogate microenvironment culture system. Figure 5.1.2 summarises the findings of MSC and
HSPC culture and their response to MDM.
The study of MSC culture on MSC-ECM demonstrated that the proliferative behaviour of these
cells was notably influenced by the culture substrate. Although preparation of 2D fibronectin
and Matrigel surfaces demonstrated superior long-term expansion than plain tissue culture
plastic, MDM substrates have been able to go beyond this effect. Enhanced proliferative
behaviour was accompanied by altered cell shape (smaller and more elongated than cells on
control substrates) and by increased secretion of cytokines such as IL-8, Ang-1 and SDF-
1. Maintenance of a small and spindle shaped morphology has been associated with higher
proliferation rates [270] and demonstrates that the extracellular environment of decellularised
matrices bears considerable advantages in comparison to simple ECM preparations of ECM
components. Furthermore, MDM also promoted enhanced proliferation into adipocytes and
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osteoblasts upon stimulation into both lineages. The absence of residual cytokines from MDM
(as observed by ELISA analysis of cytokine washes from the matrix) implies that the supportive
function of the substrate is not due to the release of remaining growth factors but more likely
due to the adhesive properties and subsequent regulatory processes. For the possible purpose
of clinical application not only large numbers of MSC are important but also the secretion of
cytokines and growth factors is crucial for MSC functionality. Most of the therapeutic beneficial
effects of MSC are exerted via paracrine mechanisms [271]. The presented culture system
demonstrated that cytokine secretion can be stimulated when MSC are in contact with MDM.
The finding of enhanced growth factor secretion is one indication that ECM stimulation alters
global MSC behaviour. Furthermore, paracrine stimulation between MSC via self-secreted
morphogens is most likely guided by the local presentation of cytokines via ECM molecules of
MDM. The extracellular microenvironment influences the physiological presentation of soluble
signalling ligands and controls their sequestration, thereby influencing the outcome of cell fate.
For example, controlled binding and release of TGF-β by biglycan and decorin proteoglycans
directs controlled proliferation and survival of marrow stromal cells. Absence of these molecules
leads to excess levels of TFG-β which in turn binds directly to its receptor and overactivates the
signalling pathway resulting in apoptosis and reduced numbers of marrow stromal cells [272].
Another aspect of environmental cell fate control is the conditioning of MSC by their niche.
Once the cells are adapted to signals of their environment they are pre-destined to follow certain
lineage spcifications. Irreversible epigenetic changes prime the cell to respond in particular ways
to further stimuli [242] which diminishes their multipotentiality. Here lies one of the reasons
why MSC cultures on plain plastic substrates or simple and flat Matrigel preparations resulted
in impaired culture outcome. This strengthens the importance of the culture environment for
maintenance of functional cellular phenotypes. This is especially important if the expanded
cell population is intended for subsequent use in specific cellular assays or for applications that
require cellular plasticity.
Another aspect that is included in this phenomenon is the alteration of cell shape on MDM. The
underlying substrate determines cell shape by topographical patterning of adhesion sites. Fur-
thermore, cell shape is altered by transduction of external elasticity into intracellular tensegrity,
dependent on the resilience of the substrate. Pioneering work by the Chang laboratory [118]
indicated that culture surface modification by presentation of micro-patterned ECM molecules
dictates cell shape and MSC cell fate into osteoblasts or adipocytes. Similarly the group around
Spatz et al. [196] has shown that activation of integrins via nanopatterned adhesive surfaces
controls the formation of focal adhesion sites and actin stress fibres, leading to altered cell
shapes and cellular responses. These processes are thought to be myosin-driven, generating
traction forces against the matrix. Also mechanisms of force-sensitive protein conformational
changes (at focal adhesion sites or within the ECM) are thought to control cell shape-mediated
cell fate decisions [241]. In contrast to the speculated elasticity driven differentiation of MSC
[51, 117], the very soft characteristics of MDM did not induce differentiation of MSC under
standard culture conditions (unless differentiation was specifically induced). This may be re-
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lated to the fact that both ECM substrates demonstrated a Young’s Modulus ranging below
the usually tested elasticities by Discher and co-workers and harbours a different effect of very
soft matrices towards MSC. As mentioned above, the BM is one of the softest tissues in the
body, and the here presented MDM were able to take on this characteristic. The property of
this very viscous matrix material should be considered for the establishment of artifical BM
stem cells culture scaffolds. In conclusion, the natural topographical presentation of adhesion
sites within MDM is a key advantage of these substrates in comparison to Matrigel or even
simpler fibronectin or plastic surfaces. Under these premises, the observed differences between
aaECM and osteoECM in supporting MSC differentiation might be attributed to their differ-
ential elasticity and or topography.
Analysing the potential of BM cell-generated extracellular matrices as in vitro niches for MSC
has become fashionable. Shortly after this thesis was initiated, studies by Chen and co-workers
demonstrated similiar effects of MSC proliferation and differentiation behaviour on MDM as
described in this thesis. In vivo-transplantation into mice revealed that the bone formation ca-
pacity of long-term ECM-expanded cells is dramatically enhanced in comparison to less potent
cells that were expanded on tissue culture plastic [243, 245, 246]. Another very recent work by
Pei et al. indicates that the beneficial effect of MDM is transduced into MSC by activation of
integrin α2 and β5 and by activation of proliferation related ERK1/2 and cyclin D1 pathways
[273]. In line with these findings cell-cycle control has been shown to be regulated via matrix
elasticity and activation of ERK and FAK [235]. In conjunction, the here presented support
of MSC expansion and differentiation, and the mentioned findings by other groups, point out
that adhesion processes and mechano-transduction of signalling events are key mechanisms by
which MDM conduct their functionality towards MSC. Taken together, decellularised ECM
substrates function as supportive environmental niches for BM-MSC and are potent culture
systems for MSC expansion, differentiation and stimulation of cytokine secretion.
Unlike the recent interest in MSC culture on decellularised MDM, the expansion of HSPC
by such systems has not been investigated. In the past, the standard culture condition that
was used to maintain and expand haematopoietic stem cells was the so called Dexter Culture
System, which is a co-culture of stromal feeder cells together with a mix of progenitor and
premature haematopoietic cells or with enriched HSPC. As described by the hypothesis of the
stem cell synapse [75], the supportive function of feeder-based cultures is not only the direct
cell-cell contact between stromal cells and HSPC but also the secretion of HSPC-supporting
factors by stromal cells (soluble and ECM ligands). Today, HSPC are mainly cultured in sus-
pension with little opportunity for cell attachment, only controlled by the addition of cytokines.
In this study, MDM provide a matrix for cell attachment of HSPC and thereby provide more
natural cues for stem cell regulation. The data from this thesis demonstrate that MDM have
the potential to support the expansion of CD34+ progenitor cells by upto 3-fold (for aaECM
substrates). Thereby, a constant number of progenitor cells was maintained expressing early
stem cell markers CD34 and CD133 in comparison to an exhaustion of those cells on tissue
culture plastic or fibronectin coated substrates. Although not significantly different, osteoECM
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substrates did not support HSPC as robust as aaECM, which indicates that the properties of
osteoECM are not as optimal for HSPC culture as those of aaECM. Analysis of the differen-
tial effects of both substrates might help to identify the mechanisms by which HSPC can be
stimulated for enhanced ’self-renewing’ proliferation. The true stem cell phenotype of HSPC
is classically demonstrated, not only by cell surface marker expression, but moreso by their
ability to reconstitute the haematopoietic system in lethally irradiated recipient mice after
transplantation of ex vivo manipulated cells. Ongoing transplantation experiments of human
ECM-expanded HSPC into SCID (severe combined immunodeficiency) mice will reveal the
amount of true stem cells expanded or maintained by the MDM system.
On both culture substrates, HSPC demonstrated close interaction and strong adhesion to the
underlying matrices. For a fraction of cells this adhesion was accompanied by a change in cell
shape, demonstrating a more flat and cobblestone-like morphology. A recent study by Jing et
al. [247] investigated MSC-HSPC co-cultures and found that the fraction of more immature
progenitor cells exhibited a flat morphology and was located underneath the stromal cell layer
in close contact with the underlying matrix. Similarly, 3D culture systems of HSPC, for
example in ECM functionalised microcavities also presented more adhesion sites to progenitor
cells and resulted in stem cell maintenance [126]. The close contact of HSPC to MDM can also
be explained by the presence of the chemoattractant SDF-1 in MDM substrates. As shown
in Appendix A, SDF-1 has been deteced in MDM, but is was listed as extracellular matrix
annotated although it is a secreted product of MSC [274]. SDF-1 has been shown to control stem
cell homing from the circulation back to the niche via interaction with CXCR4 receptors on the
cell surface of HSPC [78]. The presence of SDF-1 in MDM indicates that homing-related signals
are an important aspect for ex vivo HSPC-supportive substrates to spatially present migratory
gradient-signals which are able to cause directed stem cell interaction with the niche. SDF-1 has
also been suggested to mediate HSPC expansion [248], which could be one of the responsible
factors for the detected elevated proliferation levels of HSPC on MDM. By interaction with
MDM presented SDF-1, receptor levels of CXCR4 on HSPC might change and cause different
signalling events that determine further behaviour of the cells in culture, which would be absent
in control cultures due to the lack of the ligand. As it was already stressed for the regulation
of MSC, the MDM substrate provides an adhesive environment that contains binding sites
for HSPC cell surface receptors and thereby enables the specific interaction between HSPC
and ECM components. As many studies have highlighted the regulation of HSPC by stromal
cell proteoglycans [45], the here presented culture substrate includes all molecular aspects
to mediate cytokine adhesion and interaction with progenitor cells. Only small amounts of
cytokines have been added into the medium and resulted in a measureable difference between
MDM and control substrates. Application of even higher doses of growth factors might augment
the proliferative capacity even further. These findings indicate that close interaction of HSPC
with the ECM substrate stimulate signalling cascades that can maintain HSPC stemness. This
hypothesised maintenance of early progenitors within the ECM compartment probably leads
to reduced exhaustion of stem cells irrespective of extensive proliferation.
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In conclusion, also the third aim of this thesis was successfully accomplished. Taken together,
many ECM intrinsic factors are involved and are necessary for the composition of native extra-
cellular environments. The use of optimal physiological substrates may replace or complement
existing approaches to support and expand stem cells ex vivo. The here presented system of de-
cellularised bone marrow-surrogate matrices is one route to achieve optimal culture conditions
for MSC and HSPC in a controllable and tuneable way.
Figure 5.1.2: Response of bone marrow stem and progenitor cells to decellularised matrices
Mesenchymal and haematopoietic stem and progentor cells cultured on MSC-generated decellularised matrices
demonstrate intense cell-substratum interactions, accompanied by morphological changes and enhanced prolifer-
ative activity. MSC secrete elevated levels of soluble ligands and show robust differentiation into adipocytes and
osteoblasts upon inductive stimulation.
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From the presented work in this thesis four important conclusions can be drawn:
ﬃ The reliable use of decellularised matrix substrates can be highly improved by appliance
of polymer-mediated covalent binding of fibronectin and subsequent anchorage of cell-
secreted extracellular matrix molecules.
ﬃ Generation of decellularised matrices is variable by means of cellular-stimulation during
the process of matrix segregation. Furthermore, the system can be transferred to other
cell types for tissue-specific generation of decellularised ECM substrates.
ﬃ Detailed analysis of decellularised matrix extracts and its characteristics demonstrates the
intricate and complex nature of BM-MSC extracellular constituents. Combined presence
of all ECM intrinsic properties determines substrate functionality.
ﬃ Niche-like decellularised MDM can support expansion and differentiation of tissue-specific
stem and progenitor cells (MSC and HSPC) in vitro and permit insight into control
mechanisms of stem cell self-renewal and cell fate decisions. The system can be exploited
to produce defined artificial stem cell niches in an ex vivo setting.
This brings us back to the initial idea of this project. The ability of the extracellular matrix
to instruct cellular phenotype should not be underestimated when thinking how artificial en-
vironments orchestrate stem cell function. The extracellular matrix should be regarded as an
entity with versatile, but yet specific functions. The presented studies have highlighted that
progenitor cells of the bone marrow are regulated by the complex interplay with the ECM in
a more natural manner when using organ specific ECMs than by standard culture regimes or
reconstituted ECM preparations with no organ specificity.
The results gained within this thesis work are promising but also imply the requirements for
further research strategies. To fully understand the mechanisms by which extracellular matrices
regulate stem cell self-renewal, survival and cell fate more detailed analysis have to follow. The
outlook in this last section will give ideas and possibilities how to continue facilitating this
system for further research applications.
5.2 Outlook
The establishment of BM-specific decellularised matrices and their detailed characterisation
is the starting point for manifold following investigations exploiting the value of this culture
system. The possible potential is seen in clinical applications, as basic research model system
or for the progression of bioengineering approaches. The entity of possible applications allows
further insight into the BM stem cell niche.
The established system demonstrates a great potential to be used as a culture substrate for
expansion of BM progenitor cells. Both cell types, MSC and HSPC, are valuable cell sources
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for cellular therapies of degenerative or malignant disorders. For clinical applications large
numbers of cells are necessary to achieve curative effects. Further development of this system
permits one to achieve of controlled ex vivo expansion of stem cells. For example autologous
cells could be expanded and applied as direct cellular transplants or in conjunction with in-
telligent biomaterials that guide the regeneration process. MSC are attractive cell sources for
therapeutic applications, given their potential for tissue repair and immunosuppressive proper-
ties [275, 276]. Decellularised matrices have shown extensive expansion of MSC over long-term
culture periods. To shorten long expansion times, a larger surface area coated with decellu-
larised matrices would allow to expand more cells in a shorter time frame. Since the ECM
composition was demonstrated to be largely reproducible between different MSC donors it
would be of great assistance for the expansion of patient-MSC if allogeneic MSC from healthy
donors could be utilised to generate MDM layers. For example using MDM from young donors
could be especially beneficial for the expansion and rejuvenation of MSC from older patients,
like it was shown by animal experiments of Sun et al. [246]. Furthermore, the use of immortal-
ised MSC-cell lines for preliminary preparation of ECM substrates might be worth considering.
Of course, further investigation needs to be done to analyse the impact of donor age, gender,
time-frame for ECM preparation and appropriate MSC yield, before this system could be trans-
lated into the clinic. Similar tactics would apply for the expansion of HSPC. Transplantation
of HSPC is used for the treatment of a variety of genetic disorders, blood cancers or diseased
bone marrow. Here, different cell sources such as peripheral blood, cord blood and bone mar-
row progenitor cells could be further analysed for their expansion on decellularised matrices in
conjunction with growth factor and morphogen supplements.
On the other hand this system is not only valuable for possible future clinical applications,
it also holds a great potential for basic research of cell-ECM interactions and ECM-mediated
stem cell regulation. Thereby, MDM serve as a model system to probe a multitude of mech-
anisms and regulatory pathways that are affected by ECM topography, elasticity, adhesion
ligands and signalling domains. Specifically, this includes adhesion and integrin activation pro-
cesses, transduction of extracellular signals into intracellular tensegrity, cell shape regulation
of signalling cascades and changes in gene expression and cellular phenotype. One approach
could be targeted manipulation of specific ECM molecules by si-RNA knock-down or function
blocking experiments and investigation of the cellular response. Others could be the detailed
analysis of adhesion receptors involved in cell survival, proliferation and differentiation in con-
tact with MDM. The variability of the model system also lies within the possiblity to study
uptake and release of soluble growth factors and cytokines. Presentation of soluble ligands via
glycosaminoglycans plays an important role for functional cellular interaction. For example
biomaterials must also function as a reservoir for growth factors and cytokines that can be re-
leased in a timely manner or are presented as a gradient for optimal cellular stimulation. The
system might also help to progress the development of serum free culture conditions. Either
pre-loaded tissue specific cytokines (for HSPC) or self-secreted growth factors (by MSC) are
more effectively presented and preserved by the matrix, minimising the need for undefined
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serum supplementation. Another very interesting application of MDM is the use as native
environment for the study of cancer cells or cancer stem cells in interaction with extracellular
surroundings and in response to chemotherapy.
Third, the system can also serve as a guiding point for ongoing improvement and development
of biomaterials for bio- and tissue-engineering applications. Thoroughly characterised MDM
are most valuable reference systems for the rational design of multi-biofunctional polymer
matrices. The field of bioengineered materials for the control of stem cell behaviour has made
great advancements over the last years. Once the underlying mechanisms of stem cell control via
ECM interactions are better understood minimal criteria for artifical (man-made and not cell-
made) surrogate systems can be refined. Clearly, the native extracellular matrix and recreations
of it provide a very fundamental basis for the engineering of scaffolds and cellular substrates.
The use of an intelligent combination of the identified crucial BM niche cues can help to
accelerate this process. It is not only important that a substrate provides a myriad of adhesion
sites for cells and signalling molecules but also the right physical properties that direct cellular
maintenance or differentiation into the desired cell type. The presented MDM system can
serve as a blueprint for the design of structures that control cellular response. The future
complex biomaterial must combine sufficient presentation of adhesion sites, possible via peptide
sequences, artificial reconstitution of natural ECM shapes, presentation of functional signalling
molecules and elastic 3D properties in a tuneable and cell-interactive manner. Combined
efforts of basic research, nanotechnology and chemical engineering will help to approach optimal
conditions for ex vivo and in vivo control of stem and progenitor cell behaviour.
As we progress to appreciate the multi-functionality and complexity of natural extracellu-
lar matrices by fabrication of analogous model systems - either as complex as decellularised
matrices or by mimicking subsets of selected ECM properties - we can foster and accelerate
the intelligent design of new biomaterials for tissue engineering and regenerative medicine.
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